CHEMESIS INTERNATIONAL INC. - and - GEM YIELD BAHAMAS LTD. - and - GEM GLOBAL YIELD FUND LLC SCS - and - THE SHARE LENDERS DIRECT PLACEMENT AGREEMENT DIRECT PLACEMENT AGREEMENT

EXHIBIT 6.22

Execution Version

DATED AS OF

February 22, 2019

CHEMESIS INTERNATIONAL INC.

- and -

GEM YIELD BAHAMAS LTD.

- and -

GEM GLOBAL YIELD FUND LLC SCS

- and -

THE SHARE LENDERS

DIRECT PLACEMENT AGREEMENT

THIS AGREEMENT is made on February 22, 2019

BETWEEN:

(1)	Chemesis International Inc., a company incorporated under the laws of British-Columbia having an office at 0000-000 Xxxxxxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxx-Xxxxxxxx X0X 0X0, Xxxxxx (the "Company");

(2)	GEM Global Yield Fund LLC SCS, (together with its permitted successors and assigns), a company incorporated under the laws of Luxembourg whose registered office is at 000X, xxxxx x’Xxxx, X-0000 Xxxxxxxxxx (the "Investor");

(3)	GEM Yield Bahamas Ltd., a company incorporated in Delaware whose principal place of business is at 000 Xxxx Xxxxxx, 0^xx Xxxxx, Xxx Xxxx, XX 00000, XXX ("GEMYB"); and

(4)	The persons whose names and addresses are set out in Schedule 2 of this Agreement (the "Share Lenders").

WHEREAS:

(A)	The Investor wishes to subscribe, on the terms and subject to the conditions set out in this Agreement, for securities of the Company with an aggregate sale price of up to CDN$10,000,000.

(B)	An Initial Direct Placement shall be completed for CDN$3,000,000 no later than 10 days after the signing of this Agreement (the “Initial Direct Placement”).

(C)	The Share Lenders wish, on the terms set out in this Agreement, to lend Common Shares (as defined herein) to the Investor.

NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual covenants, agreements, representations and warranties hereinafter set forth and the sum of CDN$10 paid by each Party to the other and other good and valuable consideration, the Parties hereto agree as follows:

IT IS AGREED:

1.	DEFINITIONS

1.1	The following terms used in this Agreement shall, unless the context otherwise requires, bear the following meanings:

	"Acceptance Notice"		shall have the meaning given in clause 1.1(e);

	"Acceptance Period"		shall have the meaning given in clause 1.1(a);

	"Affiliate"		has the meaning given to such term in the Securities Act (British Columbia);

-2-

	"Applicable Securities Laws"		the applicable securities laws in the Provinces of British Columbia, Alberta and Ontario and the respective rules, regulations, instruments, blanket orders and blanket rulings under such laws together with applicable published policies, policy statements and notices of the Applicable Securities Regulator and the Listing Rules;

	"Applicable Securities Regulators"		the securities commissions or securities regulatory authorities in the provinces of British Columbia, Alberta and Ontario;

	"Bloomberg"		Bloomberg Financial Markets;

	"Business Day"		any day (except any Saturday or Sunday) on which banks in New York, Vancouver, British Columbia and Toronto, Ontario are generally open for business;

	"CDN"		the lawful currency of Canada;

	“Change of Control”		means the acquisition of Common Shares of the Company as a result of which a person, group of persons or persons acting jointly or in concert, or persons associated or affiliated within the meaning of the Business Corporations Act (British Columbia) with any such person, group of persons or any of such persons (collectively “Acquirors”), beneficially own or exercise control or direction over Common Shares such that the Acquirors would beneficially own or exercise control or direction over Common Shares which would entitle them to cast more than 50% of the votes attaching to all Common Shares;

	"Closing Bid Price"		for Common Shares as of any date, the last closing bid price for such shares on the Exchange as reported by Bloomberg or, if no such closing bid price is reported for such shares by Bloomberg, the last such closing trade price of such shares that is reported by Bloomberg, in each case appropriately adjusted for any Variations (to the extent that any such Variation has not already been reflected in such closing bid or trade price);

	"Closing Date"		shall have the meaning given in clause 3.3;

	"Closing Price"		for Common Shares as of any date, shall be the last closing price for such shares on the Exchange as reported by Bloomberg or, if no such closing price is reported for such shares by Bloomberg, the last such closing trade price of such shares that is reported by Bloomberg, in each case appropriately adjusted for any Variations (to the extent that any such Variation has not already been reflected in such closing or trade price);

-3-

	"Commitment Period"		the period commencing on the date of this Agreement and expiring on the earlier of: (a) 24 months from the date of this Agreement; and (b) the date on which the Investor has subscribed for Common Shares with an aggregate Purchase Price of CDN$10,000,000;

	"Common Shares"		Common Shares in the capital stock of the Company;

	"Daily Trading Volume"		with respect to any Trading Day, the trading volume of the Common Shares on the Exchange, as reported by Bloomberg, provided that block trades as reported by Bloomberg and single trades of 50,000 Common Shares or more, commonly known as single account cross trades, shall be disregarded for the purpose of calculating such trading volume;

	"Designated Officer"		any director or officer of the Company, the secretary of the Company or such other person as is designated by the board of directors of the Company;

	"Exchange"		the Canadian Securities Exchange;

	"Excluded Day"		any Trading Day during an Acceptance Period: (a) on which: (i) the amount equal to 90 per cent of the Closing Bid Price is less than the applicable Purchase Price or (ii) the Common Shares are not traded on the Exchange; or (b) in respect of which the Investor makes an election in accordance with clause 1.1(f)

	"Fee"		has the meaning given in clause 1.1(a);

	"Floor Price"		CDN$1.75 or the minimum purchase price set by the Company in each Placement Notice below which the Company does not wish to issue Common Shares pursuant to such Placement Notice; the price may be different in each Placement Notice ;

	"Group"		the Company and its Subsidiaries collectively and any body corporate or entity which directly or indirectly controls or is under common control with the Company, collectively;

-4-

	“Initial Direct Placement”		has the meaning given in the preamble.

	"Investor's Brokerage Account"		the Investor's brokerage account which will provide the Investor with access to clearing and settlement services in the Settlement System in respect of the Common Shares;

	"Lien"		with respect to any asset, any mortgage, lien, pledge, encumbrance, charge, hypothec or security interest of any kind in or on such asset or the revenues or income therefrom save in so far as they arise or are created by operation of law or in the normal course of trading;

	"Listing"		admission to listing (if applicable) on the Exchange and any applicable official list and trading on the Exchange, and the terms "List" and "Listed" shall be construed accordingly;

	"Listing Rules"		the rules and policies of the Exchange applicable to a Listed company from time to time;

	"Loan"		has the meaning given in clause 1.1(a);

	"Loan Shares"		has the meaning given in clause 1.1(a);

	"Market Out"		the right of the Investor to decline to purchase Common Shares in connection with a Placement Notice on one or more occasions if the Exchange refuses to accept or approve any subscription to or issuance of, any Common Shares pursuant to this Agreement for any reason whatsoever, including in respect of the Purchase Price;

	"Market Price"		Closing Bid Price on the Exchange for the fifteen (15) Trading Days, or 30 Trading Days if so elected by the Investor pursuant to clause 1.1(b) preceding the relevant date;

	"Material Adverse Event"		any event or series of events which has led or may reasonably be expected to lead to (a) any material adverse effect on the business, operations, properties or financial condition or prospects of the Group, taken as a whole, (b) any condition, circumstance or situation that would prohibit or interfere with the ability of any member of the Group from performing or otherwise materially interfere with the authority or ability of any member of the Group to perform its obligations under or in respect of this Agreement or the Common Shares, (c) the Common Shares ceasing to be Listed, or (d) the Listing of the Common Shares, or trading in Common Shares on the Exchange, being suspended for five (5) or more consecutive Trading Days;

-5-

	"Material Change in Ownership”		any event or series of events which has led or may reasonably be expected to lead to any circumstance that the officers and directors of the Company own less than 20% of the outstanding Securities.

	“Notice Date”		the date of delivery of a relevant Placement Notice;

	"Person"		an individual or a corporation, a general or limited partnership, a trust, an incorporated or unincorporated association, a joint venture, a limited liability company, a limited liability partnership, a joint stock company, a government (or an agency or political subdivision thereof) or any other entity of any kind;

	"Placement Maximum"		the maximum number of Common Shares which can be stated in each Placement Notice such that:

			(i) the number does not exceed 1,000 per cent of the average Daily Trading Volume during the 15 Trading Days, or 30 Trading Days if so elected by the Investor pursuant to cluse 1.1(b) immediately preceding the date of the relevant Placement Notice; and

			(ii) the number does not exceed such amount as, when multiplied by 90 percent of the Closing Price on the Trading Day immediately prior to the issue of the relevant Placement Notice, and then added to the aggregate Purchase Price of all the Common Shares subscribed for pursuant to all prior closings, would be greater than CDN$10,000,000;

	"Placement Notice"		a notice completed by the Company at any time during the Commitment Period and submitted to the Investor in the form attached hereto as Exhibit A;

	"Placement Pricing Period"		a period of 15 consecutive Trading Days, or 30 Trading Days if so elected by the Investor pursuant to clause 1.1(b), or in the case of the Initial Direct Placement, 10 Trading Days days, preceding a placement closing date;

-6-

	"Promissory Note"		a promissory note in the form set out at Exhibit B;

	“Purchase Price”		shall mean, per Common Share, an amount equal to the greater of (i) 90 per cent of the Market Price for the relevant Acceptance Period, excluding any Excluded Day; and (ii) the Floor Price;

	"Rejection Notice"		shall have the meaning given in clause 1.1(e);

	"Required Approvals"		shall have the meaning given in clause 1.1(g);

	“Securities”		means the Common Shares issuable pursuant to an Acceptance Notice, the Warrants and the Underlying Common Shares;

	"Securities Act"		the United States Securities Act of 1933, as amended;

	"Settlement System"		the system for electronic settlement of trades in Common Shares on the Exchange operated by CDS Canadian Clearing and Depository Services Inc. or other relevant entity with respect to a different Exchange on which the Common Shares are listed or jurisdiction in which the Common Shares are listed;

	“Share Lender Purchase Notice”		shall have the meaning given in clause 1.1(f);

	"Solvent"		with respect to any Person on a particular date, such Person being able to pay its debts as they are generally due;

	"Subscription Amount"		subject to the Placement Maximum, the aggregate number of Common Shares stated in each Placement Notice (which number may be different in each Placement Notice) that the Company wishes the Investor to subscribe for;

	"Subscription Day"		the Trading Day immediately preceding the date of the applicable Placement Notice;

	"Subsidiary"		has the meaning given to such term in the Securities Act (British Columbia);

	"Trading"		trading of the Common Shares on the Exchange;

-7-

	"Trading Day"		a day on which the Exchange is open and remains open for not less than 5 hours for general trading of securities;

	“Underlying Common Shares”		means the Common Shares issuable upon exercise of the Warrants;

	"United States" and "U.S. Person"		shall have the respective meanings set out in Regulation S Rule 902(k) under the Securities Act;

	"Variation"		any variation to the share capital of the Company (including without limitation any subdivision, consolidation, capitalisation issue or scrip dividend or any issue of new shares other than for arm's-length consideration) or any change of nominal value after the date of this Agreement;

	"Warrant Agreement"		the warrant agreement in respect of Warrants to be entered into pursuant to this Agreement in the form set out in Exhibit F;

	“Warrant Delivery Date”		shall have the meaning set out in clause 5.4;

	"Warranties"		the statements made in clauses 4 and 6;

	"Warrants"		the warrants to be issued pursuant to this Agreement in the form set out in Exhibit F;

	"Warrants Payment"		shall have the meaning set out in clause 5.4.

1.2	References to clauses, Schedules and Exhibits are, save where the context otherwise requires, to clauses of and schedules and exhibits to this Agreement.

2.	PLACEMENT NOTICE

2.1	Delivery of Placement Notice

	Subject to and in accordance with the terms, conditions and provisions of this Agreement, the Investor hereby agrees to purchase, pursuant to the Initial Direct Placement, CDN$3,000,000 of Common Shares, which at the date hereof would represent 1,630,434 Common Shares at CDN$1.84 per Common Share. The final subscription price for such Common Shares and the final number of Common Shares, shall be adjusted, if necessary, in the final and relevant documents relating to such subscription, as set out herein. The Placement Pricing Period for the Initial Direct Placement shall be 10 Trading Days.

-8-

Subject to the satisfaction (or waiver in writing by the Investor) of the conditions set forth in clause Error! Reference source not found., on any Trading Day during the Commitment Period, the Company shall be entitled (but in no circumstances obligated) to issue a Placement Notice to the Investor, and, if such Placement Notice is issued, shall provide a copy of such Placement Notice to the Share Lenders. The Placement Notice shall be completed as required and duly executed and shall:

	(i)	specify the Floor Price and the Subscription Amount (as inserted by the Company); and

	(ii)	be delivered on each occasion in the form of a duly completed Exhibit A.

	A Placement Notice shall be irrevocable. The Company may issue as many Placement Notices as it may elect (each Placement Notice constituting a “placement”) during the Commitment Period provided that, after delivery of a Placement Notice, the Company may not, without the prior consent of the Investor, thereafter deliver a further Placement Notice until the expiry of the Acceptance Period relating to the Placement Notice already delivered.

2.2	Conditions Precedent to the Delivery of a Placement Notice

	The Company may issue a Placement Notice only if the following conditions have been and remain satisfied (or waived by the Investor in writing in respect of the relevant Placement Notice):

	(a)	the Company shall have delivered, and the Investor shall have received copies, of this Agreement and the Promissory Note duly executed by the Company, and those agreements remain in full force and effect, enforceable against the Company in accordance with their terms and the Share Lenders shall have delivered and the Investor shall have received a copy of this Agreement duly executed by the Share Lenders, and this Agreement shall remain in full force and effect, enforceable against the Share Lenders in accordance with its terms;

	(b)	the Share Lenders shall have delivered the Common Shares, free trading and unrestricted, to which the Placement Notice relates in electronic form into the account of the Investor;

	(c)	the Promissory Note has been duly executed and delivered to the Investor;

	(d)	the Company has obtained all the Required Approvals (if any) in respect of the particular placement (in a form reasonably acceptable to the Investor) and such Required Approvals (if any) are in full force and effect such that 1,000 per cent of the number of Common Shares contemplated by the Placement Notice (or, if 90 per cent of the Closing Price on the Trading Day on which a Placement Notice is sent when (i) multiplied by 1,000 per cent of the number of Common Shares contemplated by the Placement Notice and (ii) added to the aggregate Purchase Price of all Common Shares already issued pursuant to Closing Notices would exceed CDN$10,000,000, such smaller number of Common Shares (being not less than 100 per cent of the number of Common Shares contemplated by the Placement Notice) as is capable of being issued without exceeding such CDN$10,000,000 limit) may be duly allotted and issued to the Investor;

-9-

	(e)	the issuance of Common Shares to the Investor will not require the Company to obtain the approval of its shareholders;

	(f)	the Common Shares remain Listed on the Exchange;

	(g)	the representations and warranties of the Company contained herein are true and correct in all material respects as of the relevant Subscription Day as repeated at that time by and with respect to the Company (except that representations and warranties that are expressed by their terms to be made as of a specific date need be true in all respects only as of such date);

	(h)	the Company and each Share Lender, have performed, satisfied and complied in all material respects with all covenants, obligations, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company or the Share Lender (as the case may be) at or prior to the date of the Placement Notice;

	(i)	no inquiry, investigation or other proceeding, whether formal or informal, has been commenced, announced or threatened, no order has been issued by any governmental or regulatory organisation or stock exchange and there has been no change of law or policy, or the interpretation or administration thereof, which operates or could operate to prevent, suspend, hinder, delay, restrict or otherwise have a significant adverse effect on the transactions contemplated by this Agreement or which could have a material adverse effect on the Investor;

	(j)	Listing of the Common Shares has not been suspended or threatened to be suspended by the Exchange during the 20 Trading Days prior to the relevant Subscription Day;

	(k)	there shall have been no reasonable allegation of fraud committed by or on the part of the Company, its officers, directors or shareholders and affiliates or their respective officers or directors;

	(l)	no Material Adverse Event or Material Change in Ownership has occurred or is reasonably expected to occur; and

	(m)	the Placement Maximum has not been reached.

2.3	Acceptance or Rejection of Placement Notice

	(a)	Investor shall, subject to clause 2.3, within a period of either 15 Trading Days, or 30 Trading Days if so elected by the Investor pursuant to clause 1.1(b), from the receipt of a Placement Notice from the Company, (the period, as elected being the "Acceptance Period") accept or, if any condition set forth in clause Error! Reference source not found. has not been met or the right of Market Out exists, reject the Placement Notice.

	(b)	Depending on market conditions, the Investor shall, at his sole discretion, extend the Acceptance Period up to a total of 30 days with interim closing if requested by the Company.

-10-

	(c)	Investor will wire the required funds to the Company in accordance with particulars provided by the Company from time to time on the first Trading Day after the expiry of an Acceptance Period.

	(d)	In the event that the Common Shares to which the Placement Notice relates exceed the Placement Maximum, Investor shall not be obligated to accept it and it shall automatically be null and void upon providing notice thereof to the Company and for greater certainty, the Acceptance Period shall be deemed to have expired in respect of such Placement Notice.

	(e)	In the event that the Common Shares to which the Placement Notice relates do not exceed the Placement Maximum, and the right of Market Out does not exist, no later than the last Business Day of an Acceptance Period, the Investor shall issue an "Acceptance Notice" in the form set forth as Exhibit C hereto. The Acceptance Notice shall specify how many Common Shares the Investor is purchasing, which shall be up to 200% of the Common Shares in any Placement Notice (and such total shall be subject to the dilution limits under the rules and policies of the Exchange). The Investor shall not be obligated to subscribe more than 50% of the Common Shares in any Placement Notice.

	(f)	In the circumstances in which the Market Out right exists, the Investor may deliver a “Rejection Notice” in the form set forth in Exhibit D hereto. In circumstances where the Investor has delivered a Rejection Notice to the Company, the Investor shall have the right, which right shall exist so long as this Agreement is in force, to elect to purchase Common Shares directly from the Share Lenders upon three Business Days’ notice to the Share Lenders (the "Share Lender Purchase Notice" in the form set forth as Exhibit E hereto). The Share Lender Purchase Notice shall specify how many Common Shares the Investor is purchasing, which shall be between 50 per cent and 200 per cent of the Common Shares contemplated by the Placement Notice less 1/15^th, or 1/30^th if so elected by the Investor pursuant to clause 1.1(b) of the total shares for each Excluded Day. In the event that Investor elects to purchase the Common Shares directly from the Share Lenders, Investor and the Share Lenders hereby agree that, within three Business Days of the Share Lender Purchase Notice, Investor shall wire to one or more accounts designated by the Share Lenders an amount or amounts equal to the purchase price therefor. The price for the Common Shares so purchased from the Share Lenders shall be the Purchase Price.

	(g)	For the purpose of calculating the obligation of the Investor during an Acceptance Period, if there has been a Material Adverse Event on any Trading Day during an Acceptance Period, the Investor shall be entitled, at its sole discretion, to elect to treat such Trading Day and any further Trading Day following such Trading Day during the relevant Acceptance Period as an Excluded Day.

	(h)	In the event where there is an Excluded Day, this day shall be excluded from the average price calculation and the Investor’s purchase obligation shall be reduced by 1/15^th or1/30th if so elected by the Investor pursuant to clause 1.1(b).

	(i)	The Company shall issue a Placement Notice in respect of the Initial Direct Placement as soon as practicable following the date hereof.

-11-

2.4	Fee

	Provided that the Initial Direct Placement is completed:

	(a)	The Company shall pay to GEMYB a fee equal to the aggregate Purchase Price, being CDN$200,000 (the "Fee") payable, irrespective of whether any Placement Notices have been delivered, upon the soonest of: (i) the occurrence of the first three placements hereunder that occur after the Initial Direct Placement, (ii) 12 months from the date of this Agreement, (iii) a Change of Control of the Company; (iv) the occurrence of a Material Adverse Event; (v) the occurrence of Material Change in Ownership;

	(b)	The Fee (and any applicable interest thereon pursuant to clause 1.1(f)) shall be payable in cash;

	(c)	The Company shall, on the date of this Agreement, provide a Promissory Note as evidence of its obligation to pay the Fee;

	(d)	The Investor shall be entitled to set off, on behalf of GEMYB, such Fee against the Purchase Price for any placement which the Investor shall be obligated to pay to the Company. Any such set off or assignment shall be without prejudice to any other rights or remedies which the Investor may have against the Company;

	(e)	If for any reason:

	(i)	the Company fails to comply with its obligations to pay the Fee;

	(ii)	the Company has breached in any material respect any representation, warranty, covenant or agreement contained in this Agreement and (if such breach is curable) such breach is not cured within 5 Business Days following receipt by the Company of notice of such breach or there has been any Material Adverse Event;

	(iii)	the Company ceases to carry on business at any time before the Fee is paid; or

	(iv)	any steps are taken by any person to initiate any form of bankruptcy, insolvency, wratorship, tutorship or administration proceedings in relation to the Company before the Fee is paid,

	the Fee at that time shall become immediately due and payable.

-12-

	(f)	Notwithstanding the foregoing, in the event this Agreement is terminated by the Company pursuant to clause 8.4 below or if the Investor refuses to purchase Common Shares in connection with a Placement Notice delivered by the Company to the Investor pursuant to the terms and conditions of this Agreement for which the right of Market Out does not apply, the outstanding balance of the Fee at such time shall cease to be due and payable by the Company to GEMYB and the Promissory Note shall be terminated and duly surrendered by GEMYB to the Company; and

	(g)	If any sum payable under this clause 1.1(f) is not paid on the due date of payment, interest shall accrue on such sum from and including the due date for payment to but excluding the date on which payment is made at a rate of 5 per cent above the base rate of Barclays Bank PLC from time to time.

	Notwithstanding the foregoing, in the event that the Initial Direct Placement is not completed due to the failure to meet or non-fulfillment of any conditions hereunder (other than by reason of the Investor's breach of its representations, warranties and/or undertakings in this Agreement), then Sections 2.4(a) – (g) shall not be conditional upon completion of the Initial Direct Placement. GEMYB hereby represents, warrants and covenants to the Company that all actions by the GEMYB hereunder shall at all times be in compliance with applicable laws in all material respects.

3.	SUBSCRIPTION FOR COMMON SHARES

3.1	Delivery of Placement Notice & Share Lending

	The Share Lenders shall be deemed, upon receipt of any Placement Notice, to offer (the "Offer") to lend Common Shares to the Investor on the following terms:

	(a)	the total number of Common Shares which shall be offered for loan (the "Loan") (excluding any Common Shares which have already been loaned and which have not yet been returned to the relevant Share Lender by the Investor pursuant to such loan) (the "Loan Shares") shall be equal to 100 per cent of the Subscription Amount;

	(b)	the Investor shall be deemed to accept the Offer in full unless it shall have notified the Share Lenders otherwise on or prior to the date which is three (3) Trading Days after the date of the Placement Notice;

	(c)	the Investor's Brokerage Account to be used for each delivery of Loan Shares shall be designated by the Investor not later than two (2) Trading Days after the delivery of a Placement Notice;

	(d)	the Share Lenders shall together deliver the Loan Shares to the Investor's Brokerage Account promptly upon and, in any case, no later than three (3) Business Days from, being informed of the account information as contemplated by paragraph (c) above;

	(e)	the Loan Shares shall be freely transferable and unrestricted. In the event that the Loan Shares are not freely tradable and unrestricted, the Placement Notice shall be null and void; and

	(f)	subject to the reference to nominal consideration in the Recitals to this Agreement, the Share Lenders shall receive no consideration in connection with the Offer.

-13-

3.2	Further Terms of Share Lending

	(a)	Subject to clause 3.5, each Loan shall be concluded for a term commencing on the date of delivery of the Loan Shares to the Investor and ending on the day on which the Investor shall have discharged its obligations in respect thereof.

	(b)	The delivery of the Loan Shares to the Investor shall constitute a “loan” of the relevant securities, not a sale or other disposition of such securities, and accordingly beneficial ownership of the Loan Shares shall not pass to the Investor upon the delivery of the Loan Shares. Notwithstanding the foregoing sentence, until the date set for return of the Loan Shares under clause Error! Reference source not found.(d), the Investor shall have all of the incidents of ownership of the Loan Shares, including the right to transfer or trade the Loan Shares to others, except for the voting rights attached to the Loan Shares, which rights shall remain with the Share Lenders.

	(c)	Where the number of Loan Shares transferred to the Investor by the Share Lenders in connection with a Placement Notice is greater than the Subscription Amount specified in the corresponding Placement Notice, the Investor shall return to the Share Lender any Loan Shares received in excess of the Subscription Amount without undue delay, but in any case by no later than the first Business Day on which the Settlement System is in operation following the Closing Date.

	(d)	Immediately upon the Investor being issued Common Shares directly by the Company pursuant to this Agreement, the Investor shall use such Common Shares towards the repayment of any balance of the relevant Loan by transferring (or instructing a third party to transfer) a number of Common Shares which is equal to the number of outstanding Loan Shares to the Share Lenders.

	(e)	Where there is at any time more than one Share Lender, (i) their obligations under this Agreement are undertaken by them jointly and severally; and (ii) subject to clause 3.5, the Share Lenders shall be responsible for telling the Investor to which of them any Common Shares are to be transferred or rights to receive Common Shares are to be assigned and any Loan Shares are to be returned.

3.3	Subscription Closing

	Notwithstanding the provisions herein (except clause 2.1, to which this clause 3.3 is subject), the Company may request interim closings upon 5 days written notice with any necessary adjustments to be made to the ultimate subscription amount.

	Subject to:

	(a)	the satisfaction (or waiver in writing by the Investor) of the conditions set out in clause Error! Reference source not found. as at the Subscription Day;

-14-

	(b)	the subscription and payment for the Common Shares pursuant to the relevant fully completed and duly executed Placement Notice and the Listing of such Common Shares not being prohibited or enjoined (temporarily or permanently) by any applicable law or governmental or other regulation including the Listing Rules (other than by reason of the Investor's breach of its representations, warranties and/or undertakings in this Agreement); and

	(c)	no change having become effective between the date of this Agreement and each Closing Date, in any law or regulation (whether governmental or otherwise) which would adversely affect in any material aspect the holding or disposal of Common Shares by the Investor or the Investor's rights in respect thereof:

	no later than three (3) Business Days following the approval of the Exchange or, if the Settlement System is not in operation on that day, the next Trading Day on which the Settlement System is in operation (each, a "Closing Date"), the Company shall issue to the Investor the Common Shares subscribed for by the Investor against payment by the Investor of the Purchase Price in respect thereof. For the avoidance of doubt, the Closing Date for the Initial Direct Placement shall be the date that is the 10^th Trading Day following the date of the Placement Notice in respect of the Initial Direct Placement (the “Initial Placement Closing Date”), and the time periods for acceptance or rejection of a Placement set forth in Section 2.3 shall not apply to the Initial Direct Placement. For the avoidance of doubt, in the event that the Initial Direct Placement does not complete by the Initial Placement Closing Date, then any Loan Shares that may have been delivered by the Share Lender to the Investor pursuant to this Agreement shall be returned forthwith, and in any event, within three Trading Days of the Initial Placement Closing Date, to the Share Lender.

3.4	Replacement of Share Lenders

	A Share Lender may withdraw from this Agreement subject to notifying the Company and the Investor of its intention thereof and subject to a notice period of not less than 90 days. The Investor shall thereafter not have any obligations under this Agreement until one or more persons has executed a deed of adherence in which they confirm that they have become a party to this Agreement in the capacity of a Share Lender and agree to be bound by all applicable terms of this Agreement.

3.5	Substitution of Share Lenders

	Notwithstanding clause (e), the Company may, at its sole discretion and at any time, request any Share Lender which has lent Loan Shares to the Investor, to be substituted with another Share Lender. Such substitutions should be completed pursuant to the terms and conditions of this Agreement adapted as required.

-15-

3.6	Warranties of the Share Lenders

	The warranties in this clause 3.6 shall be deemed to have been repeated as at each Subscription Day, as at each Closing Date and as at each date on which Common Shares become issued and Listed pursuant to this Agreement with reference to the facts and circumstances existing on that date. Each Share Lender hereby represents warrants and undertakes to the Investor that the following statements are true and accurate in all respects:

	(a)	such Share Lender has the requisite power and authority to enter into and to consummate the transactions contemplated hereby and otherwise to carry out its obligations hereunder;

	(b)	such Share Lender is the legal and beneficial owner of any Loan Shares it loans pursuant to this Agreement;

	(c)	the Loan Shares are freely tradeable and not subject to any statutory or other hold period or restriction on resale applicable to the Share Lender or the Loan Shares;

	(d)	such Share Lender is not required to obtain any consent, waiver, authorisation or order of, or make any filing or registration with, any court or other governmental or regulatory authority or other Person (including, without limitation, the approval of its director(s)) in connection with the execution, delivery and performance by it of this Agreement and as of the Subscription Day and as of the Closing Date any necessary consents and approvals have been obtained and remain in full force in respect of the lending of the Loan Shares;

	(e)	such Share Lender is resident in the place of incorporation as set out at Schedule 2.

4.	REPRESENTATIONS WARRANTIES AND UNDERTAKINGS OF THE COMPANY

4.1	The Company hereby represents warrants and undertakes to the Investor that the Warranties are true and accurate in all respects in respect of the Company as at the date of this Agreement. The Warranties shall be deemed to have been repeated by the Company as at each Subscription Day, as at each Closing Date and as at each date on which Common Shares become issued and Listed pursuant to this Agreement with reference to the facts and circumstances existing on that date.

	(a)	Organisation and Qualification

		The Company and each of its Subsidiaries is duly incorporated and validly existing under the laws of its jurisdiction of incorporation with the requisite corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted.

	(b)	Organisation of Share Capital

		Common Shares for so long as this Agreement remains in force, will remain the only class of shares in the equity share capital of the Company (where "equity share capital" refers to the issued shares of capital stock of the Company, excluding any class of shares which neither as respects dividends nor as respects capital carry any right to participate beyond a specified amount in the distribution) and the Company shall not for so long as this Agreement remains in force issue any shares in the equity share capital of the Company which have rights differing from those attaching to the equity share capital in issue as at the date of this Agreement.

-16-

(c)

Authorisation; Enforcement

	(i)	The Company has and shall have the requisite corporate power and authority to enter into this Agreement and on each Closing Date, to consummate the transactions contemplated by this Agreement that are to be consummated on that Closing Date and otherwise to carry out its obligations under this Agreement.

	(ii)	The execution and delivery of this Agreement and the completion by it of the transactions required hereby and thereby have been and will be duly authorised by all necessary action on the part of the Company, its directors and its shareholders.

	(iii)	This Agreement has been duly executed and delivered by the Company or on its behalf and the obligations assumed by the Company under this Agreement constitute and will constitute valid and binding obligations of the Company, enforceable against each of them in accordance with their terms.

	(d)	Share Capital

		As at the Subscription Day, the issue of the Common Shares which may be issued as a result of the relevant Placement Notice will not be subject to any pre-emptive right to acquire, option, right of first offer or first refusal or similar rights.

	(e)	Issue of Common Shares

		The Company will have on each Subscription Day and corresponding Closing Date, an adequate reserve of authorised but unissued Common Shares to enable it to allot and issue the number of Common Shares equal to the Subscription Amount set forth in the relevant Placement Notice and if applicable, the number of the Underlying Common Shares issuable pursuant to the exercise of Warrants issued in connection with the relevant Placement Notice. When issued pursuant to this Agreement, the Securities shall be free of any Liens, duly authorised, validly issued, fully paid and non- assessable, and application shall be made forthwith for such Common Shares and if applicable, Underlying Common Shares, to be Listed.

	(f)	No Conflicts

		The execution, delivery and performance of this Agreement and the issue of Securities by the Company pursuant to this Agreement, and the completion by the Company, of the transactions contemplated hereby, do not and will not conflict with or violate any provision of their constating documents.

	(g)	Consents and Approvals

		Except for any necessary approvals from the Exchange, including with respect to the Listing of Common Shares issued pursuant to a Placement Notice and the internal approvals referred to in clause 1.1(c)(ii), none of the Company or any Subsidiary is or shall be required to obtain any consent, waiver, authorisation or order of, or make any filing or registration with, any court or the Exchange in connection with the execution, delivery and performance of this Agreement and the issue of the Securities under each Placement Notice. As of Closing Date, any necessary consents and approvals from the Exchange in respect of the Securities required to be issued pursuant to any Placement Notice (collectively, the "Required Approvals") shall have been obtained and shall be in full force and effect. The Company will, however, be required to file, following the issuance of any Securities hereunder or report in Form 45-106F1, within the prescribed period of time. The Company shall procure that all Loan Shares are Listed at all times, that all Common Shares and if applicable, Underlying Common Shares issued pursuant to this Agreement shall, subject to the Listing of the Common Shares already in issue remaining effective, be Listed with effect from the opening of business on the Trading Day after their issue date.

-17-

	(h)	Litigation; Proceedings

		There is no action, suit, notice of violation, proceeding or investigation pending or, to the best knowledge of the directors of the Company, threatened against the Company or any of its Subsidiaries or any of their respective properties or assets before or by any court, governmental or administrative agency or regulatory authority which (i) relates to or challenges the legality, validity or enforceability of this Agreement; or (ii) could, individually or in the aggregate, be reasonably expected to impair materially the ability of the Company to perform fully on a timely basis its obligations under this Agreement.

	(i)	Exchange

		On each Subscription Day, the Company shall be unaware of any reason why the Exchange will not consent to and/or List the maximum number of Common Shares and if applicable, Underlying Common Shares, which may be issued pursuant to the applicable Acceptance Notice.

	(j)	Non-Public Information

		On each Subscription Day and each Closing Date, it is acknowledged that none of the Investor or any of its representatives or agents has been provided with any material information regarding or related to the Company or its operations, personnel, technologies or prospects that has not otherwise been made publicly available.

	(k)	No Insolvency or Bankruptcy

		No member of the Group is insolvent or bankrupt, has committed any act of insolvency or bankruptcy. No transfer of property has been or is being made by any member of the Group and no obligation has been or is being incurred by any member of the Group in connection with the transactions contemplated by this Agreement or related documents with the intent to hinder, delay or defraud creditors of any member of the Group.

-18-

	(l)	Public Disclosure

		The documents required to be filed by the Company under the disclosure obligations under Applicable Securities Laws (the "Public Disclosure") have, are, at all times, and will have, been filed and conform in all material respects to the requirements of the Applicable Securities Laws. Such documents at the time of their filing: (i) are true and correct in all material respects; (ii) do not contain any misrepresentations; and (iii) do not omit to state a fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances in which they will be made.

4.2	As at each Closing Date and as at each date on which Common Shares are to be issued pursuant to this Agreement, the Company shall be deemed to represent and warrant to the Investor that there shall have been no Material Adverse Event which occurred or became public or generally known, or which is reasonably expected to occur.

4.3	The Investor is entering into this Agreement and will subscribe for Common Shares in reliance on the representations, warranties, undertakings and covenants of the Company contained in this Agreement.

5.	ISSUE OF WARRANTS

5.1	The Company shall issue and deliver, concurrently with the closing of the Initial Direct Placement, to the Investor, Warrants in accordance with this clause 5 “Issue of Warrants”, in the form set out in Exhibit F, that are exercisable within five (5) years of the date hereof to purchase up to (at the option of the Investor) 2,857,000 common shares. The Warrants shall have an exercise price, subject to adjustments as set out in Schedule F, of CDN$2.50.

5.2	For greater certainty, in respect of Warrants not issued on the date of this Agreement, delivery of a Placement Notice and an Acceptance Notice under clause 2.1 and the closing of a subscription under clause 3.3 shall be deemed to be a subscription for Common Shares and Warrants for such period as Warrants are issuable pursuant to this clause 5. The foregoing is without prejudice to the rights of the Investor under clause 5.4 in relation to the Warrants Payment in circumstances where the Warrants Payment becomes payable.

5.3	On the first anniversary of the date of this Agreement, if the Market Price of the Common Shares is less than 90 per cent of the then-current exercise price of the Warrants, the exercise price of any Warrants issued shall adjust to 105 per cent of the Market Price of the Common Shares at that time, subject to the approval of the Exchange.

5.4	Regardless of whether there is any subscription for or purchase of Common Shares under this Agreement, if the Company does not issue all of the Warrants by the date that is 18 months from the date hereof (the “Warrant Delivery Date”) for any reason whatsoever, including failure to obtain approval of the Exchange, the Company shall indemnify and pay the Investor a cash payment equal to the higher of 8 per cent of the exercise value (the exercise price of the Warrant multiplied by the number of Warrants that have not been issued of any Warrants not yet issued as calculated on the Warrant Delivery Date (the “Warrants Payment”).

-19-

5.5	The Share Lenders hereby agree that if any Underlying Common Shares are subject to any restriction or hold period, they shall lend such number of Common Shares as is equal to the relevant number of Underlying Common Shares to the holder on the terms set out in Schedule F.

5.6	The Warrants Payment shall be payable in cash by the Company on the first Business Day after the 18-month period referenced in clause 5.4 has elapsed (the “Warrant Payment Date”) by wire transfer (for same day value on the first Business Day after the Warrant Payment Date) to an account of which the Investor shall have given written details to the Company for this purpose. Upon payment of the Warrant Payment, the Company shall have no further obligation to issue Warrants pursuant to this clause 5.

5.7	The Warrants are assignable with the Company’s prior written consent, which shall not be unreasonably withheld.

5.8	For certainty, except if the Investor refuses to make a requested investment as described in clause 5.4 above, as at the date of this Agreement, the Company has an obligation to the Investor (i) to deliver Warrants to purchase up to nine point nine (9.9) per cent of the Common Shares on a fully diluted basis in accordance with this clause 5, or, (ii) if fewer than such number of Warrants are issued within 18 months of the date of this Agreement, the Warrants Payment as calculated in accordance with clause 5.4.

6.	REPRESENTATIONS, WARRANTIES AND UNDERTAKINGS OF THE INVESTOR

6.1	The Investor hereby represents, warrants and undertakes to the Company that the following statements are true and accurate in all respects. The warranties are deemed to be repeated on each Subscription Day, each Closing Date and each date on which Common Shares are issued pursuant to this Agreement.

	(a)	Organisation Authority

		The Investor is a company duly formed, validly existing and currently resident under the laws of Luxemburg. The Investor has the requisite power and authority to enter into and to consummate the transactions contemplated hereby and otherwise to carry out its obligations hereunder. The subscription for Common Shares and if applicable Warrants, pursuant to this Agreement by the Investor has been duly authorised by all necessary action on part of the Investor, its directors and shareholders. This Agreement has been duly executed and delivered by the Investor or on its behalf and the obligations assumed by the Investor pursuant to this Agreement are valid and legally binding obligations of the Investor, enforceable against the Investor.

-20-

	(b)	Non-U.S. Person Status

		The Investor is organised in Luxemburg and the Investor is not a U.S. Person and is subscribing for the Common Shares and if applicable, Warrants, pursuant to, and subject to the terms and conditions of, this Agreement in offshore transactions within the meaning of Regulation S under the Securities Act.

	(c)	No Registration in the United States

	(i)	The Investor is aware that the Securities have not been, and will not be, registered under the Securities Act or the securities laws of any state, territory or district of the U.S. or any “blue sky” laws and that these Securities may not be offered or sold directly or indirectly in the U.S. without registration under the Securities Act or compliance with requirements of an exemption from registration and the Investor acknowledges that the Company have no present intention of filing a registration statement under the Securities Act in respect of such Securities and that no representation in that regard were otherwise made by the Company;

	(ii)	The Investor will not offer or sell the Securities in the United States unless such Securities are registered under the Securities Act and all applicable state securities or “blue sky” laws of the United States or an exemption from such registration requirements is available.

	(iii)	The offer to purchase Securities was not made to the Investor in the United States.

	(iv)	At the time of the applicable Acceptance Notice and at the time this Agreement was executed and delivered, the Investor (or the Investor’s authorized signatory) was outside of the United States.

	(d)	Regulatory Filings

		If Applicable Securities Laws so require, the Investor will sign, deliver and file or will assist the Company in filing the reports, commitments and other documents relating to the creation, issue and/or sale of the Securities that may be required by a securities commission, a stock exchange or another regulator, within the prescribed deadlines.

	(e)	Sale of Common Shares

	(i)	The Investor shall not at any time during the Commitment Period sell Common Shares exceeding the number of Common Shares which it owns and/or has the right to subscribe for pursuant to outstanding Placement Notices.

	(ii)	The Investor undertakes that it shall not on any Trading Day sell Common Shares exceeding such number as represent one 1/15^th of the Common Shares which it owns and/or has the right to subscribe for pursuant to an outstanding Placement Notice.

	(iii)	The Investor undertakes that during the Commitment Period it will not acquire, and the Investor shall not, notwithstanding any terms hereof, be obligated to acquire or subscribe for, any Common Shares which would in aggregate take its holding to more than 9.9 per cent of the outstanding Common Shares of the Company at any given time.

-21-

	(f)	Accredited Investor

		The Investor is purchasing Securities as principal, for its own account and not for the benefit of another party and the Investor is an “accredited investor” (“Accredited Investor”) as such term is currently defined in National Instrument 45-106 entitled Prospectus Exemptions (Regulation 45-106 respecting prospectus and registration exemptions in British Columbia) under paragraph (n) of such definition.

	(g)	Resale of Securities

		Other than as set out in this Agreement, the Investor does not have any current intention to sell the Securities and it will comply with Applicable Securities Laws concerning the purchase, holding and resale of the Securities.

	(h)	Financial Risks

		The Investor acknowledges that it is able to bear the financial risks associated with an investment in the Securities issuable hereunder. The Investor is capable of evaluating the risks and merits of an investment in the Securities by virtue of its experience as an investor and its knowledge, experience, and sophistication in financial and business matters and the Investor is capable of bearing the entire loss of its investment in same.

	(i)	Directed Selling Efforts

		Neither the Investor nor any of its affiliates, nor any person acting on its or their behalf has engaged in or will engage in any form of general solicitation or general advertising with respect to offers or sales of the Securities, including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media, or broadcast over radio, or television, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising.

	(j)	Short Selling Restriction

		The Investor covenants from and after the date hereof through and including date of termination of this Agreement, that none of the Investor, its Affiliates, associates, partners or insiders will hold a net short position in Common Shares.

-22-

	(k)	Restrictions on Resales

		In effecting any resales of Common Shares, the Investor will not engage in any sales, marketing or solicitation activities of the type undertaken by underwriters in the context of an offering of securities. The Investor will not:

	(i)	advertise or otherwise hold itself out as a dealer;

	(ii)	purchase or sell securities as principal from or to customers;

	(iii)	carry a dealer inventory in securities;

	(iv)	quote a market in securities;

	(v)	extend or arrange for the extension of credit in connection with securities transactions;

	(vi)	run a book of repurchase and reverse repurchase agreements;

	(vii)	use a carrying broker for securities transactions;

	(viii)	lend securities to customers;

	(ix)	participate in a selling group; or

	(x)	during an Acceptance Period, together with any affiliate, associate and subsidiaries, sell Common Shares.

	(l)	Unaffiliated Dealer

		The Investor will not solicit offers to purchase Common Shares and will effect all sales of Common Shares through a dealer unaffiliated with the Investor and the Corporation and appropriately registered under Applicable Securities Laws.

	(m)	Exchange Approval

		The Investor acknowledges and agrees that each placement of Securities will be subject to approval of the Exchange and there can be no guarantee that the Exchange will approve any issuance of Common Shares or Warrants beyond the first placement. Notwithstanding this clause, the Fee and the Warrant Payment shall be due and payable in accordance with the terms of this Agreement, regardless of whether or not Exchange approval is granted (however, the Investor acknowledges that without Exchange approval, the Fee may only be paid in cash (rather than in Common Shares) and in such circumstance the Company shall be obliged to pay the Fee in cash only).

	(n)	No conflict

		The execution, delivery and performance of this Agreement, and the completion by the Investor, as applicable, of the transactions contemplated hereby, do not and will not conflict with or violate any provision of its constating documents or with any agreement to which the Investor is a party.

-23-

	(o)	Consents and Approvals

		The Investor is not required to obtain any consent or authorization in connection with the execution, delivery and performance by the Investor of this Agreement.

6.2	The Investor acknowledges that the Company is entering into this Agreement and will issue the Common Shares and if applicable, Warrants, in reliance on the representations, warranties, undertakings and covenants of the Investor contained in this Agreement.

7.	OTHER AGREEMENTS OF THE PARTIES

7.1	PURPOSE

	The subscription monies received by the Company pursuant to this Agreement shall be used for working capital and general corporate purposes.

7.2	Exclusivity

	The Company agrees not to enter into a direct placement agreement structured as a share subscription facility (an issue of shares to financial investors structured over time with each tranche and placement made at the discretion of the Company) or a similar agreement with any investors other than GEMYB or the Investor until February 22, 2023. This provision does not limit the Company from raising funds by any other means.

7.3	Solicitation Materials

	In relation to this Agreement, other than as may be required by law or any regulation, the Company and its Affiliates and any Person acting on their behalf have not and shall not: (i) distribute any offering materials in connection with the offering and issuance of Securities; or (ii) solicit any offer to buy or sell such Securities by means of any form of general solicitation or advertising; or (iii) engage in any "directed selling efforts" as such term is defined in Rule 902 under the Securities Act; or (iv) take any action which would subject the issue of such Securities to registration requirements or to any securities laws of any applicable jurisdiction.

7.4	No Endorsement or Recommendation

	No agency, government entity, regulatory body, stock exchange or other entity has made any finding or determination as to the merit for investment of, nor have any such agencies or government entities made any recommendation or endorsement with respect to, the Securities. Neither the Company, nor any person acting on their behalf has given to the Investor any undertaking, written or oral, relating to the future value or price of the Securities.

-24-

7.5

Resale Restrictions and Legends

	(a)	Securities issued from treasury may be subject to certain resale and transfer restrictions under Applicable Securities Laws.

	(b)	The Investor and each Share Lender have been advised to consult their own legal advisors with respect to applicable resale and transfer restrictions and that it is solely responsible for complying with such restrictions.

	(c)	In this regard the Investor and each Share Lender acknowledges that, under certain Applicable Securities Laws, the following legend will be required on any certificates representing any Securities issued from treasury, as applicable:

"UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE [INSERT THE DATE THAT IS 4 MONTHS AND A DAY AFTER THE CLOSING DATE]."

8.	TERMINATION

8.1	Automatic Termination

	This Agreement shall automatically terminate at the end of the Commitment Period provided the Fee has been paid and, if the Warrants issuable under Clause 5 have not been issued, the Warrants Payment has been paid.

8.2	Termination by Mutual Consent

	This Agreement may be terminated at any time during the Commitment Period by the mutual consent of the Company, the Investor and GEMYB.

8.3	Termination by the Investor

	This Agreement may be terminated forthwith during the Commitment Period by the Investor by giving written notice of such termination to the Company if: (a) the Company has breached in any material respect any representation, warranty, covenant or agreement contained in this Agreement (including, without limitation, any failure to issue and/or, procure the Listing of Common Shares on time) and (if such breach is curable) such breach is not cured within 5 Business Days following receipt by the Company of notice of such breach; (b) there has been any event which is a Material Adverse Event; (c) there has been a change in applicable law which materially impacts the Investor's obligations under this Agreement; or (d) any Common Shares of the Company are delisted from the Exchange.

8.4	Termination by the Company

	This Agreement may be terminated forthwith during the Commitment Period by the Company: (i) if the Investor or GEMYB has breached in any material respect any representation, warranty, covenant or agreement contained in this Agreement and (if such breach is curable) such breach is not cured within 5 Business Days following receipt by the Investor of notice of such breach of this Agreement; or (ii) after payment of the Fee and Warrants Payment, if applicable.

-25-

8.5	Effect of Termination

	In the event of the termination of this Agreement pursuant to this clause 8 the Parties shall retain all accrued rights and shall retain all rights and remain bound by all obligations under this Agreement respecting all Securities previously issued to the Investor (or its nominee) hereunder, and nothing herein shall relieve any terminating party from liability for any prior breach of any of its agreements, covenants, representations, warranties or other obligations under this Agreement or for fraud.

9.	MISCELLANEOUS

9.1	Fees and Expenses

(a)

The Company shall pay:

	(i)	all and any stamp duty or share transfer or registration or similar duties, taxes or fees arising under the laws of any jurisdiction in connection with the subscription by the Investor (or its designee(s)) in an aggregate amount not to exceed CDN$ 5,000 per placement; and

	(ii)	all legal fees and expenses incurred by itself, the Investor and GEMYB in connection with the negotiation and execution of this Agreement and the completion of this transaction contemplated by this Agreement (the “Legal Fees”) The Company has made a deposit of CDN$21,000 to Fasken Xxxxxxxxx Xxxxxxxx LLP, counsel to the Investor and GEMYB, against payment of the legal fees.

	(b)	Upon the Company completing CDN$2,000,000 in placements, the Investor shall refund the Company all Legal Fees.

	(c)	Other than as expressly set out in this Agreement, each of the Parties shall pay its own costs, fees and expenses in connection with the negotiation and execution of this Agreement and the completion of the transactions contemplated by this Agreement.

9.2	Participation Right in Equity Offerings

	The Investor shall be granted the right to participate up to 15 per cent of any equity or equity like offering of the Company during the next 12 months after the execution of this Agreement. For greater certainty, this participation right shall not apply to warrant or option exercises, nor to any issuance of securities under the Company’s equity incentive plans from time to time.

-26-

9.3	Entire Agreement

	This Agreement (including the Exhibits to it) contains the entire agreement and understanding of the Parties with respect to the subject matter of this Agreement and supersedes all prior agreements and understandings, oral or written, relating to the subject matter of this Agreement. For the avoidance of doubt, all letters and any other arrangements written or entered into prior to the date of this Agreement shall cease to be of any effect and no Party shall have any claim or right of action pursuant thereto.

9.4	Notices

	Any notice or other communication required or permitted to be given under the terms of this Agreement shall be in writing and shall be deemed to have been received upon hand delivery (receipt acknowledged) or electronic mail transmission to the address designated below (if delivered on a Business Day prior to 5:00 p.m., New York time), or on the first Business Day following such delivery (if delivered other than prior to 5:00 p.m., New York time on a Business Day). The addresses for such communications shall be: for the Investor as specified in Schedule 1; for the Share Lenders, as specified in Schedule 2; and for the Company its office at 0000-000 Xxxxxxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxx-Xxxxxxxx X0X 0X0, Xxxxxx and email address xxxxxxxxxx@xxxxxxxx.xxx, each such communication being marked for the attention of the President or, in all cases, such other address and email address as shall be notified in writing by the recipient party to the sending party from time to time. A copy of each communication to the Company (which copy shall not constitute notice) shall be sent to counsel to the Company, Xxxxxxx Xxxxx & Xxxxxxxxx LLP, attention Xxxxxx Xxxx to email address xxxxx@xxxxxxxxxxxx.xxx, or such other email address as may be provided to GEMYB by counsel to the Company from time to time.

9.5	Amendments; Waivers

	No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment, by each of the Parties, or, in the case of a waiver, by the Party against whom enforcement of any such waiver is sought.

9.6	Headings

	The headings in this Agreement are for convenience only, and shall be ignored in construing its terms.

9.7	Assignment

	No Party shall assign or otherwise transfer any of its rights under this Agreement without the consent of the other Party, which consent shall not be unreasonably withheld.

9.8	Remedies and Waiver

	The remedies provided in this Agreement shall be cumulative and in addition to all other remedies available under this Agreement or otherwise provided by law. Any delay by either Party in exercising or failing to exercise any right or remedy under this Agreement shall not constitute a waiver of the right or remedy or a waiver of any other rights or remedies and no single or partial exercise of any rights or remedy under this Agreement or otherwise shall prevent any further exercise of the right or remedy or the exercise of any other right or remedy. Any waiver of a breach of any of the terms of this Agreement or of any default hereunder shall not be deemed to be a waiver of any subsequent breach or default and shall in no way affect the other terms of this Agreement.

-27-

9.9	Survival

	The representations, warranties, covenants and agreements contained in this Agreement shall survive the signing of this Agreement, each Closing Date, the termination of the Commitment Period and the termination of this Agreement.

9.10	Counterpart Signatures

	This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each Party and delivered to the other Parties, it being understood that the Parties need not sign the same counterpart. In the event that any signature is delivered by facsimile or email transmission, such signature shall create a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile or email transmission signature page were an original thereof.

9.11	Severability

	In case any one or more of the provisions of this Agreement shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby.

9.12	Publicity

	The Company undertakes to the Investor that: (a) on or prior to the date of delivery of the first Placement Notice to the Investor pursuant to this Agreement, the Company shall notify the Exchange in accordance, where applicable, with the requirements of the Exchange, of the fact that this Agreement has been entered into by the Company; and (b) in the event that a Placement Notice is issued and the fact of such issue can reasonably be expected to constitute a material change within the meaning of the Securities Act (British-Columbia), it shall forthwith upon such issue announce details thereof in accordance, where applicable, with the requirements of the Exchange. Save to the extent required by law or by the Exchange or any other regulatory authority (in which case the Company and the Investor shall be obligated to use their respective reasonable endeavours to consult with one another), the Company and the Investor, acting promptly and reasonably, shall have the right to approve before issue any press releases or any other public statement which the other may propose to issue or make with respect to any aspect of the transactions contemplated hereby (other than any announcement required pursuant to part (b) of the first sentence of this clause 9.12).

9.13	Further Assurances

	Each Party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other Party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the completion of the transactions contemplated hereby and undertakes to collaborate with the other Parties to in connection with any request for information or proceeding of a regulatory authority.

-28-

9.14	Cost of Enforcement of this Agreement

	In the event that either the Investor or GEMYB takes any action to enforce any of the terms of, or preserve any rights under, this Agreement or to recover any sum owed to it in accordance with this Agreement, the Company shall, if the Investor or GEMYB has received judgment against the Company by a court, tribunal or other entity having jurisdiction, forthwith on demand reimburse the Investor and/or GEMYB and/or any of their Affiliates, as the case may be, for all costs and expenses (including legal fees and applicable taxes) reasonably incurred in connection with such enforcement, which reimbursement shall be capped at an amount equal to the amount of funds received by the Company from the Investor or GEMYB pursuant to this Agreement.

9.15	Acknowledgment by the Company

	The Company hereby acknowledges that:

	(a)	it has read and understood fully the content of this Agreement, and that it is entering into this Agreement on the basis of its own independent assessment of the risks and liabilities undertaken hereunder, without any representation having been made by the Investor or GEMYB or any of their Affiliates as to the effect, operation or results of this Agreement; and

	(b)	it has been advised by its own legal and financial advisers in relation to its assessment of the risks and liabilities undertaken hereunder and that neither the Investor nor GEMYB nor any of their Affiliates has provided investment advice to it in connection with the matters agreed in this Agreement or has solicited or induced the Company to enter into this Agreement.

9.16	Acknowledgment by the Share Lenders

	Each of the Share Lenders hereby acknowledges that:

	(a)	it/he/she has read and understood fully the content of this Agreement, and that it/he/she is entering into this Agreement on the basis of its own independent assessment of the risks and liabilities undertaken hereunder, without any representation having been made by the Company, the Investor or GEMYB or any of their Affiliates as to the effect, operation or results of this Agreement; and

	(b)	it/he/she has been advised by its own legal and financial advisers in relation to its assessment of the risks and liabilities undertaken hereunder and that none of the other Parties or any of their Affiliates has provided investment, legal or tax advice to such Share Lender in connection with the matters agreed in this Agreement.

-29-

9.17

Governing Law and Jurisdiction

(a)

This Agreement (together with all documents to be entered into pursuant to its which are not expressed to be governed by another law) and any dispute or claim arising out of or in connection with it or its subject matter existence, validity or termination (including non-contractual disputes or claims) is governed by and shall be construed and take effect in accordance with the exclusive laws of the Province of British Columbia and the applicable laws of Canada applicable therein, without regard to the conflict of laws principles thereof.

9.18	Dispute Resolution

	All disputes, controversies or claims between the Parties arising out of or in connection with this agreement (including its existence, validity or termination) which cannot be amicably resolved shall be finally resolved and settled under Rules of Arbitration of the American Arbitration Association (AAA) and its affiliate the International Center for Dispute Resolution (“ICDR”) in New York City. The arbitration tribunal shall be composed of one (1) arbitrator. The arbitration will take place in New York City, New York and shall be conducted in English language. The Arbitration award shall be final and binding on the Parties.

(Signature page follows)

-30-

IN WITNESS WHEREOF the Parties have executed this Agreement effective as of the 22nd day of February, 2019.

CHEMESIS INTERNATIONAL INC.		GEM GLOBAL YIELD FUND LLC SCS

Per:	/s/ Xxxx Xxxxxx	Per:	/s/ Xxxxx De Svastich
	Name: Aman Xxxxxx		Xxxxx De Svastich
	Title: President		Director

GEM YIELD BAHAMAS LTD.		SHARE LENDERS

Per:	/s/ Xxxxx X. Xxxxx		1104255 BC LTD.
	Name: Xxxxx X. Xxxxx		/s/ Xxxxxxxxx Xxxxxx
	Title:		Name: Xxxxxxxxx Xxxxxx
			Title: Director

-31-

SCHEDULE 1

CONTACT DETAILS OF THE INVESTOR AND GEMYB

Name	Address, Email address and Facsimile Number	Percentage Allocation of Common Shares

GEM Investments America, LLC.	GEM YIELD BAHAMAS LTD.	None
	000 Xxxx Xxxxxx, 0^xx Xxxxx
	Xxx Xxxx
	XX 00000
	XXX

	Tel.: 000 (000) 000 0000
	Fax: 000 (000) 000 0000

	FAO: Xxxxx Xxxxx
	xxxxxx@xxxxx.xxx

GEM GLOBAL YIELD FUND LLC SCS	GEM GLOBAL YIELD FUND LLC SCS 412F	100 per cent
	Route X’Xxxx
	X-0000
	Xxxxxxxxxx

	Tel.: 000 (000) 000 0000
	Fax: 000 (000) 000 0000

	FAO: Xxxxx Xxxxx

SCHEDULE 2

DETAILS OF SHARE LENDERS

SHARE LENDER'S NAME

SHARE LENDER'S ADDRESS AND

EMAIL ADDRESS

INITIAL PERCENTAGE

COMMITMENT OF LOAN SHARES

1104255 BC LTD.

<@>

100%

EXHIBIT A

PLACEMENT NOTICE

To: <@>

We refer to the Direct Placement Agreement (the "Agreement") dated February 22, 2019 between CHEMESIS INTERNATIONAL INC., GEM YIELD BAHAMAS LTD.; GEM GLOBAL YIELD FUND LLC SCS and certain Share Lenders. This Placement Notice is being delivered to you pursuant to clause 2.1 of the Agreement. Terms defined in the Agreement have the same meaning herein.

We understand that the Closing Bid Price for the Trading Day immediately preceding the date of this Placement Notice was CDN$<@>. The Subscription Amount is [·] Common Shares.

The Floor Price for this subscription is $ ____________ per Common Share.

In addition, we hereby elect to issue · Common Shares to GEMYB in [partial] payment of the Fee.

We hereby certify that that all conditions precedent to the delivery of this Placement Notice pursuant to the Agreement have been satisfied (or waived in writing by you.)

Signed by:

Name:

Date:

For and on behalf of

CHEMESIS INTERNATIONAL INC.

CC: [Share Lenders]

EXHIBIT B

FORM OF PROMISSORY NOTE

PROMISSORY NOTE

CHEMESIS INTERNATIONAL INC.

Date: February 22, 2019

In consideration for entry by GEM GLOBAL YIELD FUND LLC SCS (the "Investor") into the Direct Placement Agreement entered into on February 22, 2019 among CHEMESIS INTERNATIONAL INC.(the “Issuer”), GEM Yield Bahamas Ltd. (the “Beneficiary”) and the Share Lenders (as defined) on or about the date of this Promissory Note (the "Agreement"), the Issuer has agreed to pay the Fee (as defined in the Agreement) and hereby confirms as PROMISES TO PAY to the order of the Beneficiary the Fee, being the principal sum of:

CDN$200,000 (the “Principal”)

ON DEMAND at any time as set forth in Section (f) of the Agreement (the "Payment Date") together with interest on such principal sum at a rate of five (5) per cent above the base rate of Barclays Bank PLC from time to time. Interest at such rate shall accrue daily from the Payment Date and be calculated semi-annually on the basis of the actual number of days elapsed in the year of 365 days and shall be payable on demand.

The Principal (and any applicable interest thereon) shall be paid, in advance of the Payment Date, by the Issuer in cash. Any amounts of Principal pre-paid by the Issuer to the Beneficiary prior to the Payment Date shall be delivered from the amount of the Principal prior to the Payment Date.

The Issuer shall indemnify, hold harmless and defend the Investor and/or the Beneficiary against any costs or expenses, including without limitation, the legal fees and applicable taxes and disbursements incurred by the Investor and/or the Beneficiary in connection with, arising out of or in relation to the enforcement of the provisions hereof including without limitation, any action, suit, proceeding or any dispute to enforce the terms of this Promissory Note.

This note is issued pursuant to the Agreement and unless the context requires otherwise, this note is governed by the provisions of the Agreement.

This note and any dispute or claim arising out of or in connection with it or its subject matter (including non-contractual disputes or claims) is governed by and shall be construed and take effect in accordance with the exclusive laws of the Province of British Columbia and the federal laws of Canada applicable therein, without regard to the conflict of laws principles thereof. The Issuer hereby irrevocably submits to the exclusive jurisdiction of Arbitration in accordance with Section 9.18 of the Agreement for any dispute, controversy or claim.

IN WITNESS WHEREOF this promissory note is executed as a deed on the date first above written.

Executed as a deed by CHEMESIS INTERNATIONAL	)
INC. acting by:	)


	Authorised signatory
	Name:
	Title:

EXHIBIT C

FORM OF ACCEPTANCE NOTICE

TO:	CHEMESIS INTERNATIONAL INC.

DATE:	___________________________

We refer to the Direct Placement Agreement (the "Agreement") dated February 22, 2019 among GEM YIELD BAHAMA LTD., GEM GLOBAL YIELD FUND LLC SCS, the Share Lenders and yourselves. Terms defined in the Agreement have the same meaning herein. This Acceptance Notice is being delivered to you pursuant to clause 2.3 of the Agreement.

Further to the Placement Notice received on , we understand that the number of Common Shares to which the Placement Notice refers does not exceed the Placement Amount. We understand that the Closing Bid Price for the Trading Day immediately preceding the date of the Placement Notice was CDN$ and that there are Excluded Days.

This Acceptance Notice is therefore applicable to Common Shares at a price of CDN$ per Common Share for a total Purchase Price of CDN$ .

The undersigned hereby directs you to issue Common Shares, and to register and deliver such Common Shares in the name: GEM Global Yield Fund LLC SCS

GEM GLOBAL YIELD FUND LLC SCS

_____________________________

EXHIBIT D

FORM OF REJECTION NOTICE

TO:	CHEMESIS INTERNATIONAL INC.

DATE:	___________________________

We refer to the Direct Placement Agreement (the "Agreement") dated February 22, 2019 among us, GEM GLOBAL YIELD FUND LLC SCS, GEM Yield Bahamas Ltd., the Share Lenders and yourselves. Terms defined in the Agreement have the same meaning herein. This Rejection Notice is being delivered to you pursuant to clause 2.3 of the Agreement.

Further to the Placement Notice received on , we hereby reject the subscription on the basis of the existence of the Market Out.

GEM GLOBAL YIELD FUND LLC SCS

____________________________

EXHIBIT E

FORM OF SHARE LENDER PURCHASE NOTICE

TO:	THE SHARE LENDERS

DATE:	___________________________

We refer to the Direct Placement Agreement (the "Agreement") dated February 22, 2019 among us, GEM Yield Bahamas Ltd., Chemesis International Inc. and yourselves. Terms defined in the Agreement have the same meaning herein. This Share Lender Purchase Notice is being delivered to you pursuant to clause 2.3 of the Agreement.

Further to the Placement Notice received on , the Investor has [Note: insert either option (i) or (ii)] (i) sent a Rejection Notice to the Company (a copy of which is attached).

The Investor hereby exercises the right under clause (e) of the Agreement to purchase Common Shares from the Share Lenders at a price of CDN$ per Common Share.

GEM GLOBAL YIELD FUND LLC SCS

_____________________________

EXHIBIT F

FORM OF WARRANT

THIS WARRANT CERTIFICATE, AND THE SECURITIES EVIDENCED HEREBY, WILL BE VOID AND OF NO VALUE UNLESS EXERCISED ON OR BEFORE 5:00 P.M. (EASTERN STANDARD TIME) ON <@>.

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY (AND THE SECURITIES ISSUABLE ON THE DUE EXERCISE THEREOF) BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER <@>.

NEITHER THIS WARRANT NOR THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER APPLICABLE SECURITIES LAWS. BY ITS ACCEPTANCE OF THIS WARRANT, THE HOLDER REPRESENTS THAT IT IS NOT A U.S. PERSON AS THAT TERM IS DEFINED IN REGULATION S UNDER THE SECURITIES ACT AND ANY RESALE OF SUCH WARRANT WILL BE MADE ONLY (1) IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH REGULATIONS UNDER THE SECURITIES ACT OR (2) TO A PERSON WHOM THE HOLDER OF THIS WARRANT REASONABLY BELIEVES IS AN INSTITUTIONAL ACCREDITED INVESTOR (AS DEFINED UNDER THE SECURITIES ACT) IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

A RESALE OF THIS WARRANT OR THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT IN ACCORDANCE WITH REGULATIONS UNDER THE SECURITIES ACT MAY INCLUDE A TRANSACTION WHERE NO DIRECTED SELLING EFFORTS ARE MADE IN THE UNITED STATES, THE OFFER IS NOT MADE TO A PERSON IN THE UNITED STATES AND EITHER: (I) AT THE TIME THE BUY ORDER IS ORIGINATED, THE BUYER IS OUTSIDE THE UNITED STATES, OR THE SELLER AND ANY PERSON ACTING ON ITS BEHALF REASONABLY BELIEVE THAT THE BUYER IS OUTSIDE THE UNITED STATES, OR (II) IN THE CASE OF THE COMMON SHARES, THE TRANSACTION IS EXECUTED IN, OR THROUGH THE FACILITIES OF THE CANADIAN SECURITIES EXCHANGE AND NEITHER THE SELLER NOR ANY PERSON ACTING ON ITS BEHALF KNOWS THAT THE TRANSACTION HAS BEEN PRE-ARRANGED WITH A BUYER IN THE UNITED STATES.

CHEMESIS INTERNATIONAL INC.

a corporation incorporated under the laws of the Province of British-Columbia

and having its registered office at

Xxxxx 0000, 000 Xxxxxxxxx Xxxxxx, Xxxxxxxxx, XX, X0X 0X0

NO. <@>	<@> WARRANTS
	Each whole warrant entitling the holder to acquire one common share of Chemesis International Inc., subject to adjustment as set forth herein, in accordance with the terms and conditions set forth herein.

WARRANTS

THIS IS TO CERTIFY THAT for value received GEM Global Yield Fund LLC SCS, whose registered office is at 000X, xxxxx x’Xxxx, X-0000 Xxxxxxxxxx (the “Holder”) is the registered holder of the number of warrants stated above (each a “Warrant” and collectively, the “Warrants”) and is entitled for each whole Warrant represented hereby to purchase one fully paid and non-assessable common share, subject to adjustment as hereinafter provided (each a “Share” and collectively the “Shares”), in the capital of CHEMESIS INTERNATIONAL INC. (the “Corporation”), at any time and from time to time from the date of issue hereof up to and including 5:00 p.m. (Eastern Standard Time) on <@> (the “Expiry Time”), at a price per Share of CND$ @ or, if the common shares of the Corporation have been listed in the Canadian Securities Exchange, a price equal to the Closing Bid Price on the first day of trading, subject to adjustment as hereinafter provided (the “Exercise Price”), upon and subject to the following terms and conditions.

For purposes of this Warrant Certificate:

	(i)	“Shares” means the Shares which are issuable upon the exercise from time to time of these Warrants; and

	(ii)	“$” means Canadian dollars.

TERMS AND CONDITIONS

1.	At any time and from time to time at or prior to the Expiry Time (the “Exercise Period”), the Holder may exercise all or any number of whole Warrants represented hereby, upon delivering to the Corporation at its principal office noted above, this Warrant Certificate, together with a duly completed and executed subscription notice in the form attached hereto (the “Subscription Notice”) evidencing the election of the Holder to exercise the number of Warrants set forth in the Subscription Notice (which shall not be greater than the number of Warrants represented by this Warrant Certificate) and a certified cheque, money order or bank draft payable to the Corporation for the aggregate Exercise Price of all Warrants being exercised. If the Holder is not exercising all Warrants represented by this Warrant Certificate, the Holder shall be entitled to receive, without charge, a new Warrant Certificate representing the number of Warrants which is the difference between the number of Warrants represented by the then original Warrant Certificate and the number of Warrants being so exercised.

2.	The Holder shall be deemed to have become the holder of record of Shares on the date (the “Exercise Date”) on which the Corporation has received a duly completed Subscription Notice, delivery of the Warrant Certificate and payment of the full aggregate Exercise Price in respect of the Warrants being exercised pursuant to such Subscription Notice; provided, however, that if such date is not a business day in the City of Toronto, Ontario or Vancouver, British-Columbia (a “Business Day”) then the Shares shall be deemed to have been issued and the Holder shall be deemed to have become the holder of record of the Shares on the next following Business Day. Within five (5) Business Days of the Exercise Date, the Corporation shall issue and deliver (or cause to be delivered) to the Holder, by registered mail or pre-paid courier to his, her or its address specified in the register of the Corporation, one or more certificates for the appropriate number of issued and outstanding Shares to which the Holder is entitled pursuant to the exercise of Warrants. All costs, expenses, transfer taxes and other charges payable in connection with the issue and delivery of the Shares shall be at the sole expense of the Corporation (other than withholding tax, if any).

3.	The Corporation covenants and agrees that, until the Expiry Time, while any of the Warrants represented by this Warrant Certificate shall be outstanding, it shall reserve and there shall remain unissued out of its authorized capital a sufficient number of Shares to satisfy the right of purchase herein provided, as such right of purchase may be adjusted pursuant to Sections 4 and 6 of this Warrant Certificate. The Corporation represents and warrants that all Shares which shall be issued upon the exercise of the right to purchase herein provided for, upon payment of the aggregate Exercise Price at which Shares may at that time be purchased pursuant to the provisions hereof, shall be issued as fully paid and non-assessable shares and the holders thereof shall not be liable to the Corporation or its creditors in respect thereof. The Corporation further represents and warrants that this Warrant Certificate is a legal, valid and binding obligation of the Corporation, enforceable against the Corporation in accordance with its terms, provided that enforcement thereof may be limited by laws effecting creditors’ rights generally and that specific performance and other equitable remedies may only be granted in the discretion of a court of competent jurisdiction. The Corporation covenants that it will make all requisite filings under applicable laws in connection with the exercise of the Warrants and issue of Shares.

4.	In order to deliver Shares without any resale restriction to the Holder on the Exercise Date, the Corporation shall arrange for the Share Lenders to lend Common Shares to the Holder for delivery on the Exercise Date. In such cases, the loan shall be made on the following terms:

	(a) the total number of Common Shares which shall be offered for loan (the “Loan Shares”) shall be equal to the Shares to be delivered by the Corporation to the Holder on the Exercise Date; (b) the Share Lender shall deliver on the Exercise Date the Loan Shares which are to be loaned (the "Loan") to the securities account designated by the Holder in the Subscription Notice; (c) each Loan shall be concluded for a term commencing on the date of delivery of the Loan Shares to the Holder (which must not be later than the Exercise Date) and ending on the day set out in paragraph (f) below; (d) if the Corporation pays a dividend or makes a distribution to the holders of the Common Shares during the term of any Loan, the Holder shall pay to the Share Lender (at the time when the Holder receives the corresponding payment from the Corporation in accordance with indemnity set out further in this paragraph) in cash an amount equal to such dividend or distribution so made by the Corporation in respect to the Loan Shares. If the Corporation pays a dividend or makes any other distribution to the holders of Common Shares during the term of any Loan, the Corporation shall indemnify the Holder in respect of any and all sums that the Holder may incur in order to comply with this paragraph in order to pay the Share Lender the sums of any dividends or distributions, and from such sums will be deducted any net sum received by the Holder as dividend in respect to the Loan Shares;

(e) each Loan shall be instrumental to the Corporation for the purpose of this Warrant Certificate and it shall carry no consideration payable by the Holder to the Share Lender irrespective of any arrangements that may be agreed between the Corporation and the Share Lender in relation to the Loan;

(f) within one trading day after the Shares to be issued and delivered to the Holder pursuant to this Warrant have been Listed and delivered to the Holder, the Holder shall repay the balance of the relevant Loan by transferring a number of Shares which is equal to the number of outstanding Loan Shares to the Share Lender;and

(g) the Holder shall have no obligation to repay the balance of the relevant Loan, and the Share Lender shall have not right to claim for any outstanding Loan Shares, until the Shares issued pursuant to this Warrant have been issued, delivered to the Holder, registered with the share register and Listed.

The Exercise Price (and the number of Shares purchasable upon exercise) shall be subject to adjustment from time to time in the events and in the manner provided as follows:

(a)

Share Reorganization. If during the Exercise Period the Corporation shall:

	(i)	issue Shares or securities exchangeable for or convertible into Shares to holders of all or substantially all of its then outstanding Shares by way of stock dividend or other distribution, or

	(ii)	subdivide, redivide or change its outstanding Shares into a greater number of Shares, or

	(iii)	consolidate, reduce or combine its outstanding Shares into a lesser number of Shares,

	(any of such events in these paragraphs (i), (ii) and (iii) being a “Share Reorganization”), then the Exercise Price shall be adjusted as of the effective date or record date, as the case may be, at which the holders of Shares are determined for the purpose of the Share Reorganization by multiplying the Exercise Price in effect immediately prior to such effective date or record date by a fraction, the numerator of which shall be the number of Shares outstanding on such effective date or record date before giving effect to such Share Reorganization and the denominator of which shall be the number of Shares outstanding as of the effective date or record date after giving effect to such Share Reorganization (including, in the case where securities exchangeable for or convertible into Shares are distributed, the number of Shares that would have been outstanding had such securities been fully exchanged for or converted into Shares on such record date or effective date). From and after any adjustment of the Exercise Price pursuant to this Section 4(a), the number of Shares purchasable pursuant to this Warrant Certificate shall be adjusted contemporaneously with the adjustment of the Exercise Price by multiplying the number of Shares then otherwise purchasable on the exercise thereof by a fraction, the numerator of which shall be the Exercise Price in effect immediately prior to the adjustment and the denominator of which shall be the Exercise Price resulting from such adjustment.

(b)

Rights Offering. If and whenever during the Exercise Period the Corporation shall fix a record date for the issue or distribution of rights, options or warrants to all or substantially all of the holders of Shares under which such holders are entitled, during a period expiring not more than 45 days after the record date for such issue to subscribe for or purchase Shares or securities exchangeable for or convertible into Shares at a price per share to the holder (or having a conversion price or exchange price per Share) of less than 95% of the Current Market Price (as defined in Section 5 hereof) for the Shares on such record date (any of such events being called a “Rights Offering”), then the Exercise Price shall be adjusted effective immediately after the record date for the Rights Offering to a price determined by multiplying the Exercise Price in effect on such record date by a fraction:

(i)

the numerator of which shall be the aggregate of:

	(A)	the number of Shares outstanding as of the record date for the Rights Offering, and

	(B)	a number determined by dividing either

	I.	the product of the number of Shares offered under the Rights Offering and the price at which such Shares are offered,

	or, as the case may be,

	II.	the product of the exchange or conversion price per share of such securities offered and the maximum number of Shares for or into which the securities so offered pursuant to the Rights Offering may be exchanged or converted,

	by the Current Market Price of the Shares as of the record date for the Rights Offering; and

	(ii)	the denominator of which shall be the aggregate of the number of Shares outstanding on such record date after giving effect to the Rights Offering and including the number of Shares offered pursuant to the Rights Offering (including shares issuable upon exercise of the rights, warrants or options under the Rights Offering or upon the exercise of the exchange or conversion rights contained in such exchangeable or convertible securities under the Rights Offering).

	Any Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of any such calculation. To the extent that such Rights Offering is not so made or any such rights, options or warrants are not exercised prior to the expiration thereof, the Exercise Price shall then be readjusted to the Exercise Price which would then be in effect if such record date had not been fixed or if such expired rights, options or warrants had not been issued. From and after any adjustment of the Exercise Price pursuant to this Section 5(b), the number of Shares purchasable pursuant to this Warrant Certificate shall be adjusted contemporaneously with the adjustment of the Exercise Price by multiplying the number of Shares then otherwise purchasable on the exercise thereof by a fraction, the numerator of which shall be the Exercise Price in effect immediately prior to the adjustment and the denominator of which shall be the Exercise Price resulting from such adjustment.

(c)

Special Distribution. If and whenever during the Exercise Period the Corporation shall issue or distribute to all or to substantially all the holders of the Shares:

	(i)	securities of the Corporation including shares, rights, options or warrants to acquire shares of any class or securities exchangeable for or convertible into or exchangeable into any such shares, or

	(ii)	any cash (other than cash dividends made in the ordinary course), property or other assets or evidences of its indebtedness,

	and if such issuance or distribution does not constitute a Share Reorganization or a Rights Offering (any of such non-excluded events being herein called a “Special Distribution”), the Exercise Price shall be adjusted immediately after the record date for the Special Distribution so that it shall equal the price determined by multiplying the Exercise Price in effect on such record date by a fraction:

(i)

the numerator of which shall be the difference between:

	(A)	the amount obtained by multiplying the number of Shares outstanding on such record date by the Current Market Price of the Shares on such record date, and

	(B)	the fair value (as determined by the directors of the Corporation) to the holders of such Shares of such Special Distribution; and

	(ii)	the denominator of which shall be the total number of Shares outstanding on such record date multiplied by such Current Market Price of the Shares on such record date.

	Any Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of any such computation. To the extent that such Special Distribution is not so made or any such rights, options or warrants are not exercised prior to the expiration thereof, the Exercise Price shall then be readjusted to the Exercise Price which would then be in effect if such record date had not been fixed or if such expired rights, options or warrants had not been issued. From and after any adjustment of the Exercise Price pursuant to this Section 5(c), the number of Shares purchasable pursuant to this Warrant Certificate shall be adjusted contemporaneously with the adjustment of the Exercise Price by multiplying the number of Shares then otherwise purchasable on the exercise thereof by a fraction, the numerator of which shall be the Exercise Price in effect immediately prior to the adjustment and the denominator of which shall be the Exercise Price resulting from such adjustment.

	(d)	Capital Reorganization. If and whenever during the Exercise Period there shall be a reclassification or redesignation of Shares at any time outstanding or a change of the Shares into other shares or into other securities or any other capital reorganization (other than a Share Reorganization), or a consolidation, amalgamation, arrangement or merger of the Corporation with or into any other corporation or other entity (other than a consolidation, amalgamation, arrangement or merger which does not result in any reclassification or redesignation of the outstanding Shares or a change of the Shares into other securities), or a transfer of the undertaking or assets of the Corporation as an entirety or substantially as an entirety to another corporation or other entity (any of such events being herein called a “Capital Reorganization”), the Holder, where he, she or it has not exercised the right of subscription and purchase under this Warrant Certificate prior to the effective date or record date, as the case may be, of such Capital Reorganization, shall be entitled to receive, and shall accept upon the exercise of such right for the same aggregate consideration, in lieu of the number of Shares to which such Holder was theretofore entitled upon such exercise, the kind and aggregate number of shares, other securities or other property which such holder would have been entitled to receive as a result of such Capital Reorganization if, on the effective date thereof, he had been the registered holder of the number of Shares to which such holder was theretofore entitled to subscribe for and purchase; provided however, that no such Capital Reorganization shall be carried into effect unless all necessary steps shall have been taken by the Corporation to so entitle the Holder. If determined appropriate by the board of directors of the Corporation, acting reasonably and in good faith, and subject to the prior written approval of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading if required by such stock exchange or over-the-counter market, appropriate adjustments shall be made as a result of any such Capital Reorganization in the application of the provisions set forth in this Section 5 with respect to the rights and interests thereafter of the Holder to the end that the provisions set forth in this Section 5 shall thereafter correspondingly be made applicable as nearly as may reasonably be possible in relation to any shares, other securities or other property thereafter deliverable upon the exercise of any Warrant. Any such adjustments shall be made by and set forth in terms and conditions supplemental hereto approved by the board of directors of the Corporation, acting reasonably and in good faith.

	(e)	Subject to the approval of the Canadian Securities Exchange, if on February <@>, 2020 the Current Market Price of the Shares is less than 90 % of then-current Exercise Price, the Exercise Price shall be adjusted to 105% of the Current Market Price at that time.

	(f)	Subject to the approval of the Canadian Securities Exchange, if and whenever at any time after the date hereof and prior to the Expiry Time, the Corporation takes any action affecting its Shares to which the foregoing provisions of this Section 5, in the opinion of the board of directors of the Corporation, acting reasonably and in good faith, are not strictly applicable, or if strictly applicable would not fairly adjust the rights of the Holder against dilution in accordance with the intent and purposes thereof, or would otherwise materially affect the rights of the Holder hereunder, then the Corporation shall execute and deliver to the Holder an amendment hereto providing for an adjustment in the application of such provisions so as to adjust such rights as aforesaid in such a manner as the board of directors of the Corporation may determine to be equitable in the circumstances, acting reasonably and in good faith. The failure of the taking of action by the board of directors of the Corporation to so provide for any adjustment on or prior to the effective date of any action or occurrence giving rise to such state of facts will be conclusive evidence, absent manifest error, that the board of directors has determined that it is equitable to make no adjustment in the circumstances.

6.	The following rules and procedures shall be applicable to the adjustments made pursuant to Section 5:

	(a)	The adjustments provided for in Section 5 are cumulative and shall be made successively whenever an event referred to therein shall occur, and shall, in the case of adjustments to the Exercise Price be computed to the nearest one-tenth of one cent subject to the following paragraphs of this Section 6.

	(b)	No adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at least 1% in the prevailing Exercise Price and no adjustment shall be made in the number of Shares purchasable upon exercise of this Warrant Certificate unless it would result in a change of at least one one-hundredth of a Share; provided, however, that any adjustments which, except for the provisions of this Section 6(b) would otherwise have been required to be made, shall be carried forward and taken into account in any subsequent adjustment. Notwithstanding Section 5 or 6 hereof, no adjustment shall be made which would result in an increase in the Exercise Price or a decrease in the number of Shares issuable upon the exercise of this Warrant Certificate (except in respect of a consolidation of the outstanding Shares).

	(c)	No adjustment in the Exercise Price or in the number of Shares purchasable upon exercise of Warrants shall be made in respect of any event described in Section 5, other than the events referred to in Sections 5(a)(ii) and (iii), if the Holder is entitled to participate in such event on the same terms, mutatis mutandis, as if it had exercised its Warrants prior to or on the effective date or record date, as the case may be, of such event. The terms of the participation of the Holder in such event shall be subject to the prior written approval, if applicable, of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading.

	(d)	No adjustment in the Exercise Price shall be made pursuant to Section 5 in respect of the issue from time to time:

	(i)	of Shares purchasable on exercise of the Warrants represented by this Warrant Certificate;

	(ii)	of Shares to holders of Shares who exercise an option or election to receive substantially equivalent dividends in Shares in lieu of receiving a cash dividend pursuant to a dividend reinvestment plan or similar plan adopted by the Corporation in accordance with the requirements of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading and applicable securities laws; or

	(iii)	of Shares pursuant to any stock option, stock option plan, stock purchase plan or benefit plan in force at the date hereof for directors, officers, employees or consultants of the Corporation, as such option or plan is amended or superseded from time to time in accordance with the requirements of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading and applicable securities laws, and such other stock option, stock option plan or stock purchase plan as may be adopted by the Corporation in accordance with the requirements of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading and applicable securities laws;

	and any such issue shall be deemed not to be a Share Reorganization or Capital Reorganization.

	(e)	If the Corporation shall set a record date to determine the holders of the Shares for the purpose of entitling them to receive any dividend or distribution or any subscription or purchase rights and shall, thereafter and before the distribution to such shareholders of any such dividend, distribution or subscription or purchase rights, legally abandon its plan to pay or deliver such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number of Shares purchasable upon exercise of any Warrant shall be required by reason of the setting of such record date.

	(f)	As a condition precedent to the taking of any action which would require any adjustment in any of the subscription rights pursuant to this Warrant Certificate, including the Exercise Price and the number or class of shares or other securities which are to be received upon the exercise thereof, the Corporation shall take any corporate action which may, in the opinion of counsel, be necessary in order that the Corporation have unissued and reserved Shares in its authorized capital, and may validly and legally issue as fully paid and non-assessable all the shares or other securities which the Holder of such Warrant Certificate is entitled to receive on the full exercise thereof in accordance with the provisions hereof.

	(g)	For the purposes of this Warrant Certificate, “Current Market Price” of a Share at any date shall be calculated as the price per share equal to the closing price for the Shares on the principal Canadian stock exchange or, if the Shares are not listed, the over-the-counter market, on which the Shares are then listed or posted for trading on the Trading Day immediately prior to such date as reported by such exchange or market in which the Shares are then trading or quoted. If the Shares are not then traded in the over-the-counter market or on a recognized Canadian stock exchange, the Current Market Price of the Shares shall be the fair market value of the Shares as determined in good faith by a nationally or internationally recognized and independent investment dealer, investment banker or firm of chartered accountants.

	(h)	In the absence of a resolution of the board of directors of the Corporation fixing a record date for any dividend or distribution referred to in Section 5(a)(i) or any Rights Offering or Special Distribution, the Corporation shall be deemed to have fixed as the record date therefor the date on which such dividend or distribution, Rights Offering or Special Distribution is effected.

	(i)	Any question that at any time or from time to time arises with respect to the amount of any adjustment to the Exercise Price or other adjustments pursuant to Section 5 shall be conclusively determined by a firm of independent chartered accountants and shall be binding upon the Corporation and the Holder, absent manifest error. Notwithstanding the foregoing, such determination shall be subject to the prior written approval of the principal Canadian stock exchange or over-the-counter market on which the Shares are then listed or quoted for trading if required by such stock exchange or over-the-counter market. In the event that any such determination is made, the Corporation shall notify the Holder in the manner contemplated in Section 17 describing such determination.

7.	On the happening of each and every such event set out in Section 5, the applicable provisions of this Warrant Certificate, including the Exercise Price, shall, ipso facto, be deemed to be amended accordingly and the Corporation shall take all necessary action so as to comply with such provisions as so amended.

8.	In any case in which Section 5 shall require that an adjustment shall be effective immediately after a record date for an event referred to herein, the Corporation may defer, until the occurrence of such an event:

	(a)	issuing to the holder of any Warrant exercised after such record date and before the occurrence of such event, the additional Shares issuable upon such exercise by reason of the adjustment required by such event, and

	(b)	delivering to such holder any distributions declared with respect to such additional Shares after such Exercise Date and before such event;

	provided, however, that the Corporation shall deliver or cause to be delivered to such holder, an appropriate instrument evidencing such holder’s right, upon the occurrence of the event requiring the adjustment, to an adjustment in the Exercise Price and/or the number of Shares purchasable on the exercise of any Warrant and to such distributions declared with respect to any additional Shares issuable on the exercise of any Warrant.

9.	At least 21 days prior to the effective date or record date, as the case may be, of any event which requires or might require adjustment in any of the subscription rights pursuant to this Warrant Certificate, including the Exercise Price and the number of Shares which are purchasable upon the exercise thereof, or such longer period of notice as the Corporation shall be required to provide holders of Shares in respect of any such event, the Corporation shall notify the Holder of the particulars of such event and, if determinable, the required adjustment and the computation of such adjustment. In case any adjustment for which such notice has been given is not then determinable, the Corporation shall promptly after such adjustment is determinable notify the Holder of the adjustment and the computation of such adjustment.

10.	The Corporation shall maintain a register of holders in which shall be entered the names and addresses of the holders of the Warrants and of the number of Warrants held by them. Such register shall be open at all reasonable times for inspection by the Holder. The Corporation shall notify the Holder forthwith of any change of address of the principal office of the Corporation.

11.	Where the Holder is entitled to receive on the exercise or partial exercise of its Warrants a fraction of a Share, such right may only be exercised in respect of such fraction in combination with another Warrant or Warrants which in the aggregate entitle the Holder to receive a whole number of Shares. If a Holder is not able to, or elects not to, combine Warrants so as to be entitled to acquire a whole number of Shares, the Holder may not exercise the right to acquire a fractional Share, and, does not have the right to receive a cash equivalent in lieu thereof equal to such fraction of a Share multiplied by the Current Market Price.

12.	Subject as herein provided, all or any of the rights conferred upon the Holder by the terms hereof may be enforced by the Holder by appropriate legal proceedings.

13.	The registered Holder of this Warrant Certificate may at any time up to and including the Expiry Time, upon the surrender hereof to the Corporation at its principal office, exchange this Warrant Certificate for one or more Warrant Certificates entitling the Holder to subscribe in the aggregate for the same number of Shares as is expressed in this Warrant Certificate. Any Warrant Certificate tendered for exchange shall be surrendered to the Corporation and cancelled.

14.	If this Warrant Certificate becomes stolen, lost, mutilated or destroyed, the Corporation shall, on such terms as it may in its discretion acting reasonably impose, issue and deliver to the Holder a new Warrant Certificate of like denomination, tenor and date as the Warrant Certificate so stolen, lost, mutilated or destroyed.

15.	Nothing contained herein shall confer any right upon the Holder hereof or any other person to subscribe for or purchase any Shares of the Corporation at any time subsequent to the Expiry Time. After the Expiry Time this Warrant Certificate and all rights hereunder shall be void and of no value.

16.	Except as expressly set out herein, the holding of this Warrant Certificate shall not constitute a Holder hereof a holder of Shares nor entitle it to any right or interest in respect thereof.

17.	Unless herein otherwise expressly provided, any notice to be given hereunder to the Holder shall be deemed to be validly given if such notice is given by personal delivery or registered mail to the attention of the Holder at its registered address recorded in the registers maintained by the Corporation. Any notice so given shall be deemed to be validly given, if delivered personally, on the day of delivery and if sent by post or other means, on the fifth Business Day next following the sending thereof. In determining under any provision hereof the date when notice of any event must be given, the date of giving notice shall be included and the date of the event shall be excluded.

18.	This Warrant Certificate and the Warrants represented hereby may be assigned with prior written consent of the Corporation which consent shall not be unreasonably withheld.

19.	Time is of the essence hereof.

20.	This Warrant Certificate is binding upon the Corporation and its successors and assigns, provided that it shall not be assigned by the Corporation without the prior written consent of the Holder.

21.	This Warrant Certificate and the Warrants represented hereby shall be governed by the exclusive laws of the Province of British Columbia and the federal laws of Canada applicable therein, without regard to the conflict of laws principles thereof.

IN WITNESS WHEREOF this Warrant Certificate has been executed on behalf of CHEMESIS INTERNATIONAL INC. as of the _________ day of _______, 20___ .

	CHEMESIS INTERNATIONAL INC.

	By:
		Authorized Signing Officer
		Name:
		Title:

SUBSCRIPTION NOTICE

TO:

CHEMESIS INTERNATIONAL INC.

Terms used herein but not otherwise defined have the meanings ascribed thereto in the attached Warrant Certificate.

The undersigned registered Holder of the attached Warrant Certificate, hereby:

	(a)	subscribes for Shares at a price of $<@> per Share (or such adjusted price which may be in effect under the provisions of the Warrant Certificate) and in payment of the exercise price encloses a certified cheque, bank draft or money order in lawful money of Canada payable to the order of CHEMESIS INTERNATIONAL INC. or its successor corporation; and

	(b)	delivers herewith the above-mentioned Warrant Certificate entitling the undersigned to subscribe for the above-mentioned number of Shares;

	in each case in accordance with the terms and conditions set out in the attached Warrant Certificate.

		The undersigned hereby directs that the said Shares be registered as follows:

Name(s) in full	Address(es) (including Postal Code)	Number of Shares



		Total: ______

(Please print full name in which Share certificates are to be issued.)

DATED this ____________ day of ________, 20 __.



		(Signature of Subscriber)

		(Print Name of Subscriber)

		(Address of Subscriber in full)

The certificates will be mailed by registered mail to the address appearing in this Subscription Notice.

EXHIBIT G

REPRESENTATION LETTER

TO:

CHEMESIS INTERNATIONAL INC. (the "Corporation")

(Capitalized terms not specifically defined in this Exhibit G have the meaning ascribed to them in the Direct Placement Agreement to which this Exhibit G is attached)

In connection with the execution by GEMYB of the Direct Placement Agreement of which this Representation Letter forms a part, the GEMYB hereby represents, warrants, covenants and certifies to the Corporation and its counsel, that:

1.	It has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Common Shares and it is able to bear the economic risk of loss of its entire investment.

2.	It has received, for informational purposes only, a copy of the Subscription Agreement relating to the offering in the United States of the Common Shares. The Corporation has provided to it the opportunity to ask questions and receive answers concerning the terms and conditions of the Offering and it has had access to such additional information, if any, concerning the Corporation as it has considered necessary in connection with its investment decision to acquire the Common Shares.

3.	It is acquiring the Common Shares as principal for its own account, and not with a view to any resale, distribution or other disposition of the Common Shares in violation of United States federal or state securities laws.

4.	It understands and acknowledges the Common Shares have not been and the Common Shares will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and that the sale contemplated hereby is being made in reliance on a private placement exemption to "institutional accredited investors" ("Accredited Investors") that satisfy one or more of the criteria set forth) in Rule 501(a)(1), (2), (3) or (7) of Regulation D ("Regulation D") under the U.S. Securities Act in reliance on the exemption from such registration under Section 4(a)(2) of the U.S. Securities Act and Rule 506(b) of Regulation D and similar exemptions under applicable state securities laws. The Common Shares are "restricted securities" within the meaning of Rule 144(a)(3) under the U.S. Securities Act, and therefore may not be offered, resold, pledged or otherwise transferred, directly or indirectly, unless they are registered under the U.S. Securities Act or unless an exemption or exclusion from registration thereunder is available.

5.	It certifies to the Corporation that it is an Accredited Investor as defined in Rule 501(a) of Regulation D under the U.S. Securities Act because GEMYB comes within any of the following categories at the time of sale of the Common Shares to that person (please initial or place a xxxx on the appropriate lines):

_________

An organization described in Section 501(c)(3) of the United States Internal Revenue Code, a corporation, a Massachusetts or similar business trust, partnership or limited liability company, not formed for the specific purpose of acquiring the Common Shares, with total assets in excess of US$5,000,000;

_________

A trust that (a) has total assets in excess of US$5,000,000, (b) was not formed for the specific purpose of acquiring the Common Shares and (c) is directed in its purchases of Common Shares by a sophisticated person as described in Rule 506(b)(2)(ii) of Regulation D of the U.S. Securities Act;

	_________		A bank as defined in Section 3(a)(2) of the U.S. Securities Act or a savings and loan association or other institution as defined in Section 3(a)(5)(A) of the U.S. Securities Act, whether acting in its individual capacity or fiduciary capacity;

	_________		A broker or dealer registered pursuant to Section 15 of the United States Securities Exchange Act of 1934, as amended;

	_________		An insurance company as defined in Section 2(a)(13) of the U.S. Securities Act;

	_________		An employee benefit plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees that has total assets in excess of US$5,000,000;

	_________		An employee benefit plan within the meaning of the United States Employee Retirement Income Security Act of 1974, as amended, for which the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of US$5,000,000, or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;

	_________		An investment company registered under the United States Investment Company Act of 1940, as amended, or a business development company as defined in Section 2(a)(48) of that Act;

	_________		A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the United States Small Business Investment Act of 1958, as amended; or

	_________		A private business development company as defined in Section 202(a)(22) of the United States Investment Advisers Act of 1940, as amended.

6.	It acknowledges that it has not purchased the Common Shares as a result of any form of general solicitation or general advertising (as such terms are used in Regulation D under the U.S. Securities Act), including, without limitation, advertisements, articles, notices or other communications published on the internet or in any newspaper, magazine or similar media or broadcast over radio, television or other form of telecommunications, or any seminar or meeting whose attendees have been invited by general solicitation or general advertising.

7.	If in the future it decides to offer, sell, pledge or otherwise transfer any of the Securities, it will not offer, sell, pledge or otherwise transfer any of such Securities, directly or indirectly, unless:

	(a)	the transfer is to the Corporation;

	(b)	the transfer is made outside the United States in a transaction meeting the requirements of Rule 904 of Regulation S under the U.S. Securities Act ("Regulation S") and in compliance with applicable local laws and regulations;

	(c)	the transfer is made pursuant to the exemption from the registration requirement of the U.S. Securities Act provided by (i) Rule 144A under the U.S. Securities Act ("Rule 144A") to a person it reasonably believes is a qualified institutional buyer as defined in Rule 144A ("Qualified Institutional Buyer") that purchases for its own account or for the account of a Qualified Institutional Buyer and to whom notice is given that the offer, sale or transfer is being made in reliance on Rule 144A and in compliance with any applicable state securities laws of the United States, or (ii) Rule 144 thereunder, if available, and, in either case, in accordance with any applicable state securities or "blue sky" laws; or

(d)

the Common Shares are transferred in any other transaction that does not require registration under the U.S. Securities Act or any applicable state securities or "blue sky" laws; and

	it has prior to any transfer pursuant to subsection (c)(ii) or (d) (and if required by the Corporation’s registrar and transfer agent for the Common Shares, subsection (b)) furnished to the Corporation (and if applicable, the Corporation’s registrar and transfer agent) an opinion of counsel of recognized standing or other evidence reasonably satisfactory to the Corporation to the effect that such transfer does not require registration under the U.S. Securities Act and applicable state securities laws.

8.	Upon the original issuance of the Common Shares, until such time as it is no longer required under applicable requirements of the U.S. Securities Act or applicable state securities laws, the certificates representing the Common Shares (and any certificates issued in exchange or substitution for the Securities) will bear the legend set forth below:

	"THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "U.S. SECURITIES ACT"), OR ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF CHEMESIS INTERNATIONAL INC. (THE "CORPORATION") THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) PURSUANT TO THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY (I) RULE 144A UNDER THE U.S. SECURITIES ACT OR (II) RULE 144 THEREUNDER, IF AVAILABLE, AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OF THE UNITED STATES, OR (D) PURSUANT TO ANOTHER EXEMPTION OR EXCLUSION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT AND, IN ANY EVENT, IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS OF THE UNITED STATES; AND IN THE CASE OF TRANSFERS UNDER CLAUSES (C)(II) OR (D) (OR IF REQUIRED BY THE CORPORATION’S TRANSFER AGENT, CLAUSE (B)), AFTER THE HOLDER HAS FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OF RECOGNIZED STANDING OR OTHER EVIDENCE SATISFACTORY TO THE CORPORATION (AND, IF APPLICABLE, THE CORPORATION’S TRANSFER AGENT) TO THAT EFFECT. DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE "GOOD DELIVERY" IN SETTLEMENT OF TRANSACTIONS ON STOCK EXCHANGES IN CANADA." At the time of transfer outside the United States in accordance with Rule 904 of Regulation S, a new certificate, which will constitute "good delivery" in settlement of transactions on Canadian stock exchanges, will be made available to GEMYB upon provision by GEMYB of a declaration in the form attached as Schedule I to this Exhibit G or in such other form that is acceptable to the Corporation and its registrar and transfer agent, together with any other evidence, which may include a legal opinion reasonably satisfactory in form and substance to the Corporation, required by the Corporation or the registrar and transfer agent for the Common Shares. The Corporation shall use its reasonable commercial efforts to cause the registrar and transfer agent of the Corporation to remove the foregoing U.S. legend within five business days (excluding weekends and holidays) of receipt of the foregoing, as applicable.

9.	It consents to the Corporation making a notation on its records and it understands and acknowledges that the Corporation has the right to instruct the registrar and transfer agent for the Common Shares not to record a transfer by any person without first being notified by the Corporation that it is satisfied that such transfer is exempt from or not subject to registration under the U.S. Securities Act and any applicable state securities laws.

10.	It understands and acknowledges that Rule 144 under the U.S. Securities Act is not available for resales of securities of issuers that have ever had (i) no or nominal operations and (ii) no or nominal assets other than cash and cash equivalents. Therefore, if the Corporation were ever to be deemed to be, or to have ever been, such an issuer, Rule 144 under the U.S. Securities Act may be unavailable for resales of Common Shares, unless and until the Corporation has satisfied the applicable conditions.

11.	It understands and acknowledges that the Corporation is not obligated to file and has no present intention of filing with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities administrator any registration statement in respect of resales of the Securities in the United States.

12.	It understands and agrees that there may be material tax consequences to GEMYB of an acquisition, holding or disposition of the Common Shares. The Corporation gives no opinion and makes no representation with respect to the tax consequences to GEMYB under United States, state, local or foreign tax law of the undersigned’s acquisition, holding or disposition of such Common Shares and GEMYB acknowledges that it is solely responsible for determining the tax consequences of its investment. In particular, no determination has been made whether the Corporation is, or will be, a "passive foreign investment company" within the meaning of Section 1291 of the United States Internal Revenue Code of 1986, as amended.

13.	It understands and agrees that the financial statements of the Corporation have been prepared in accordance with Canadian generally accepted accounting principles and are subject to Canadian auditing and auditor independence standards, each of which differ in some respects from United States generally accepted accounting principles, auditing standards and auditor independence standards, respectively, and thus may not be comparable to financial statements of United States companies.

14.	It is aware that its ability to enforce civil liabilities under the United States federal securities laws may be affected adversely by, among other things, the fact that: (i) the Corporation is organized under the laws of British-Columbia, Canada; (ii) some of the directors and officers of the Corporation are residents of countries other than the United States; and (iii) a substantial portion of the assets of the Corporation and said persons may be located outside the United States.

15.	Upon execution of this Exhibit G by the GEMYB, this Exhibit G and Schedule I hereto shall be incorporated into and form a part of the Direct Placement Agreement to which this Exhibit G is attached.

	Dated: _________________________

	GEMYB INVESTMENTS AMERICA, LLC

	By:
		Signature


	Print name of Signatory

	Title

SCHEDULE I

TO EXHIBIT G

Declaration for removal of legend

TO:	The registrar and transfer agent for the Common Shares of CHEMESIS INTERNATIONAL INC. (the "Corporation")

RE:	Sale of Common Shares represented by certificate number

The undersigned (a) acknowledges that the sale of the Common Shares of the Corporation to which this declaration relates is being made in reliance on Rule 904 of Regulation S under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and (b) certifies that (1) the undersigned is not an affiliate (as that term is defined in Rule 405 under the U.S. Securities Act) of the Corporation, (2) the offer of such Common Shares was not made to a person in the United States and either (A) at the time the buy order was originated, the buyer was outside the United States, or the seller and any person acting on its behalf reasonably believe that the buyer was outside the United States, or (B) the transaction was executed in, on or through the facilities of the Canadian Securities Exchange or another "designated offshore securities market" as defined in Regulation S under the U.S. Securities Act and neither the seller nor any person acting on its behalf knows that the transaction has been prearranged with a buyer in the United States, (3) neither the seller nor any affiliate of the seller nor any person acting on any of their behalf has engaged or will engage in any directed selling efforts in the United States in connection with the offer and sale of such Common Shares, (4) the sale is bona fide and not for the purpose of "washing off" the resale restrictions imposed because the Common Shares are "restricted securities" (as such term is defined in Rule 144(a)(3) under the U.S. Securities Act), (5) the seller does not intend to replace the Common Shares sold in reliance on Rule 904 of Regulation S under the U.S. Securities Act with fungible unrestricted securities and (6) the contemplated sale is not a transaction, or part of a series of transactions which, although in technical compliance with Regulation S under the U.S. Securities Act, is part of a plan or scheme to evade the registration provisions of the U.S. Securities Act. Terms used herein have the meanings given to them by Regulation S under the U.S. Securities Act.

Dated:

By:
	Signature

Name	(please print)

Document Metadata

Table of Contents

Free Standard Templates

CHEMESIS INTERNATIONAL INC. - and - GEM YIELD BAHAMAS LTD. - and - GEM GLOBAL YIELD FUND LLC SCS - and - THE SHARE LENDERS DIRECT PLACEMENT AGREEMENT DIRECT PLACEMENT AGREEMENT

Document Metadata

Free Standard Templates

CHEMESIS INTERNATIONAL INC. - and - GEM YIELD BAHAMAS LTD. - and - GEM GLOBAL YIELD FUND LLC SCS - and - THE SHARE LENDERS DIRECT PLACEMENT AGREEMENT DIRECT PLACEMENT AGREEMENT

Document Metadata

Related content